The Translational Future of Stress Neurobiology and Psychosis Vulnerability: A Review of the Evidence
- Autores: Cullen A.1, Labad J.2, Oliver D.3, Al-Diwani A.3, Minichino A.4, Fusar-Poli P.4
-
Afiliações:
- Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience,, Kings College London
- , CIBERSAM,
- Department of Psychiatry, University of Oxford, Warneford Hospital
- Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies,, Institute of Psychiatry, Psychology & Neuroscience, King's College London
- Edição: Volume 22, Nº 3 (2024)
- Páginas: 350-377
- Seção: Neurology
- URL: https://rjraap.com/1570-159X/article/view/644669
- DOI: https://doi.org/10.2174/1570159X21666230322145049
- ID: 644669
Citar
Texto integral
Resumo
Psychosocial stress is a well-established risk factor for psychosis, yet the neurobiological mechanisms underlying this relationship have yet to be fully elucidated. Much of the research in this field has investigated hypothalamic-pituitary-adrenal (HPA) axis function and immuno-inflammatory processes among individuals with established psychotic disorders. However, as such studies are limited in their ability to provide knowledge that can be used to develop preventative interventions, it is important to shift the focus to individuals with increased vulnerability for psychosis (i.e., high-risk groups). In the present article, we provide an overview of the current methods for identifying individuals at high-risk for psychosis and review the psychosocial stressors that have been most consistently associated with psychosis risk. We then describe a network of interacting physiological systems that are hypothesised to mediate the relationship between psychosocial stress and the manifestation of psychotic illness and critically review evidence that abnormalities within these systems characterise highrisk populations. We found that studies of high-risk groups have yielded highly variable findings, likely due to (i) the heterogeneity both within and across high-risk samples, (ii) the diversity of psychosocial stressors implicated in psychosis, and (iii) that most studies examine single markers of isolated neurobiological systems. We propose that to move the field forward, we require well-designed, largescale translational studies that integrate multi-domain, putative stress-related biomarkers to determine their prognostic value in high-risk samples. We advocate that such investigations are highly warranted, given that psychosocial stress is undoubtedly a relevant risk factor for psychotic disorders.
Palavras-chave
Sobre autores
Alexis Cullen
Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience,, Kings College London
Autor responsável pela correspondência
Email: info@benthamscience.net
Javier Labad
, CIBERSAM,
Email: info@benthamscience.net
Dominic Oliver
Department of Psychiatry, University of Oxford, Warneford Hospital
Email: info@benthamscience.net
Adam Al-Diwani
Department of Psychiatry, University of Oxford, Warneford Hospital
Email: info@benthamscience.net
Amedeo Minichino
Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies,, Institute of Psychiatry, Psychology & Neuroscience, King's College London
Email: info@benthamscience.net
Paolo Fusar-Poli
Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies,, Institute of Psychiatry, Psychology & Neuroscience, King's College London
Email: info@benthamscience.net
Bibliografia
- Maj, M.; Os, J.; De Hert, M.; Gaebel, W.; Galderisi, S.; Green, M.F.; Guloksuz, S.; Harvey, P.D.; Jones, P.B.; Malaspina, D.; McGorry, P.; Miettunen, J.; Murray, R.M.; Nuechterlein, K.H.; Peralta, V.; Thornicroft, G.; Winkel, R.; Ventura, J. The clinical characterization of the patient with primary psychosis aimed at personalization of management. World Psychiatry, 2021, 20(1), 4-33. doi: 10.1002/wps.20809 PMID: 33432763
- Moreno-Küstner, B.; Martín, C.; Pastor, L. Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses. PLoS One, 2018, 13(4), e0195687. doi: 10.1371/journal.pone.0195687 PMID: 29649252
- Solmi, M.; Radua, J.; Olivola, M.; Croce, E.; Soardo, L.; de Pablo, S.G.; Il, S.J.; Kirkbride, J.B.; Jones, P.; Kim, J.H.; Kim, J.Y.; Carvalho, A.F.; Seeman, M.V.; Correll, C.U.; Fusar-Poli, P. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol. Psychiatry, 2022, 27(1), 281-295. doi: 10.1038/s41380-021-01161-7 PMID: 34079068
- Fusar-Poli, P.; McGorry, P.D.; Kane, J.M. Improving outcomes of first-episode psychosis: An overview. World Psychiatry, 2017, 16(3), 251-265. doi: 10.1002/wps.20446 PMID: 28941089
- Fusar-Poli, P.; Correll, C.U.; Arango, C.; Berk, M.; Patel, V.; Ioannidis, J.P.A. Preventive psychiatry: A blueprint for improving the mental health of young people. World Psychiatry, 2021, 20(2), 200-221. doi: 10.1002/wps.20869 PMID: 34002494
- Rosenthal, D. Genetic theory and abnormal behavior; McGraw-Hill: New York, 1970.
- Zubin, J.; Spring, B. Vulnerability: A new view of schizophrenia. J. Abnorm. Psychol., 1977, 86(2), 103-126. doi: 10.1037/0021-843X.86.2.103 PMID: 858828
- Walker, E.; Mittal, V.; Tessner, K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu. Rev. Clin. Psychol., 2008, 4(1), 189-216. doi: 10.1146/annurev.clinpsy.4.022007.141248 PMID: 18370616
- Walker, E.F.; Diforio, D. Schizophrenia: A neural diathesis-stress model. Psychol. Rev., 1997, 104(4), 667-685. doi: 10.1037/0033-295X.104.4.667 PMID: 9337628
- Pruessner, M.; Cullen, A.E.; Aas, M.; Walker, E.F. The neural diathesis-stress model of schizophrenia revisited: An update on recent findings considering illness stage and neurobiological and methodological complexities. Neurosci. Biobehav. Rev., 2017, 73, 191-218. doi: 10.1016/j.neubiorev.2016.12.013 PMID: 27993603
- Murray, R.M.; Lewis, S.W. Is schizophrenia a neurodevelopmental disorder? BMJ, 1987, 295(6600), 681-682. doi: 10.1136/bmj.295.6600.681 PMID: 3117295
- Howes, O.D.; Murray, R.M. Schizophrenia: An integrated sociodevelopmental-cognitive model. Lancet, 2014, 383(9929), 1677-1687. doi: 10.1016/S0140-6736(13)62036-X PMID: 24315522
- Murray, R.M.; Bhavsar, V.; Tripoli, G.; Howes, O. 30 years on: How the neurodevelopmental hypothesis of schizophrenia morphed into the developmental risk factor model of psychosis. Schizophr. Bull., 2017, 43(6), 1190-1196. doi: 10.1093/schbul/sbx121 PMID: 28981842
- Howes, O.D.; Kapur, S. The dopamine hypothesis of schizophrenia: Version III--the final common pathway. Schizophr. Bull., 2009, 35(3), 549-562. doi: 10.1093/schbul/sbp006 PMID: 19325164
- van Winkel, R.; Stefanis, N.C.; Myin-Germeys, I. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr. Bull., 2008, 34(6), 1095-1105. doi: 10.1093/schbul/sbn101 PMID: 18718885
- Mizrahi, R. Social stress and psychosis risk: Common neurochemical substrates? Neuropsychopharmacology, 2016, 41(3), 666-674. doi: 10.1038/npp.2015.274 PMID: 26346639
- Ruby, E.; Polito, S.; McMahon, K.; Gorovitz, M.; Corcoran, C.; Malaspina, D. Pathways associating childhood trauma to the neurobiology of schizophrenia. Front Psychol Behav Sci, 2014, 3(1), 1-17. PMID: 25419548
- Vargas, T.; Conley, R.E.; Mittal, V.A. Chronic stress, structural exposures and neurobiological mechanisms: A stimulation, discrepancy and deprivation model of psychosis. Int. Rev. Neurobiol., 2020, 152, 41-69. doi: 10.1016/bs.irn.2019.11.004 PMID: 32451000
- Shah, J.L.; Malla, A.K. Much ado about much: Stress, dynamic biomarkers and HPA axis dysregulation along the trajectory to psychosis. Schizophr. Res., 2015, 162(1-3), 253-260. doi: 10.1016/j.schres.2015.01.010 PMID: 25620122
- Niemi, L.T.; Suvisaari, J.M.; Tuulio-Henriksson, A.; Lönnqvist, J.K. Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophr. Res., 2003, 60(2-3), 239-258. doi: 10.1016/S0920-9964(02)00234-7 PMID: 12591587
- Sullivan, P.F.; Kendler, K.S.; Neale, M.C. Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry, 2003, 60(12), 1187-1192. doi: 10.1001/archpsyc.60.12.1187 PMID: 14662550
- Rasic, D.; Hajek, T.; Alda, M.; Uher, R. Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: A meta-analysis of family high-risk studies. Schizophr. Bull., 2014, 40(1), 28-38. doi: 10.1093/schbul/sbt114 PMID: 23960245
- Dennison, C.A.; Legge, S.E.; Pardiñas, A.F.; Walters, J.T.R. Genome-wide association studies in schizophrenia: Recent advances, challenges and future perspective. Schizophr. Res., 2020, 217, 4-12. doi: 10.1016/j.schres.2019.10.048 PMID: 31780348
- Gottesman, I.I.; Shields, J. Schizophrenia, the epigenetic puzzle; Cambridge University Press: Cambridge, New York, 1982.
- Mortensen, P.B.; Pedersen, M.G.; Pedersen, C.B. Psychiatric family history and schizophrenia risk in Denmark: which mental disorders are relevant? Psychol. Med., 2010, 40(2), 201-210. doi: 10.1017/S0033291709990419 PMID: 19607751
- Chemerinski, E.; Triebwasser, J.; Roussos, P.; Siever, L.J. Schizotypal personality disorder. J. Pers. Disord., 2013, 27(5), 652-679. doi: 10.1521/pedi_2012_26_053 PMID: 22928856
- Rosell, D.R.; Futterman, S.E.; McMaster, A.; Siever, L.J. Schizotypal personality disorder: A current review. Curr. Psychiatry Rep., 2014, 16(7), 452. doi: 10.1007/s11920-014-0452-1 PMID: 24828284
- Nordentoft, M.; Thorup, A.; Petersen, L.; Øhlenschlæger, J.; Melau, M.; Christensen, T.Ø.; Krarup, G.; Jørgensen, P.; Jeppesen, P. Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment. Schizophr. Res., 2006, 83(1), 29-40. doi: 10.1016/j.schres.2006.01.002 PMID: 16504481
- Woods, S.W.; Addington, J.; Cadenhead, K.S.; Cannon, T.D.; Cornblatt, B.A.; Heinssen, R.; Perkins, D.O.; Seidman, L.J.; Tsuang, M.T.; Walker, E.F.; McGlashan, T.H. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr. Bull., 2009, 35(5), 894-908. doi: 10.1093/schbul/sbp027 PMID: 19386578
- Fusar-Poli, P. The clinical high-risk state for psychosis (CHR-P), version II. Schizophr. Bull., 2017, 43(1), 44-47. doi: 10.1093/schbul/sbw158 PMID: 28053129
- Catalan, A. Salazar de, P.G.; Aymerich, C.; Damiani, S.; Sordi, V.; Radua, J.; Oliver, D.; McGuire, P.; Giuliano, A.J.; Stone, W.S.; Fusar-Poli, P. Neurocognitive functioning in individuals at clinical high risk for psychosis. JAMA Psychiatry, 2021, 78(8), 859-867. doi: 10.1001/jamapsychiatry.2021.1290 PMID: 34132736
- Fusar-Poli, P.; Spencer, T.; De Micheli, A.; Curzi, V.; Nandha, S.; McGuire, P. Outreach and support in South-London (OASIS) 20012020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis. Eur. Neuropsychopharmacol., 2020, 39, 111-122. doi: 10.1016/j.euroneuro.2020.08.002 PMID: 32921544
- Kotlicka-Antczak, M.; Podgórski, M.; Oliver, D.; Maric, N.P.; Valmaggia, L.; Fusar-Poli, P. Worldwide implementation of clinical services for the prevention of psychosis: The IEPA early intervention in mental health survey. Early Interv. Psychiatry, 2020, 14(6), 741-750. doi: 10.1111/eip.12950 PMID: 32067369
- Estradé, A.; Salazar de Pablo, G.; Zanotti, A.; Wood, S.; Fisher, H.L.; Fusar-Poli, P. Public health primary prevention implemented by clinical high-risk services for psychosis. Transl. Psychiatry, 2022, 12(1), 43. doi: 10.1038/s41398-022-01805-4 PMID: 35091529
- Salazar de Pablo, G.; Estradé, A.; Cutroni, M.; Andlauer, O.; Fusar-Poli, P. Establishing a clinical service to prevent psychosis: What, how and when? Systematic review. Transl. Psychiatry, 2021, 11(1), 43. doi: 10.1038/s41398-020-01165-x PMID: 33441556
- Oliver, D.; Arribas, M.; Radua, J.; Salazar de Pablo, G.; De Micheli, A.; Spada, G.; Mensi, M.M.; Kotlicka-Antczak, M.; Borgatti, R.; Solmi, M.; Shin, J.I.; Woods, S.W.; Addington, J.; McGuire, P.; Fusar-Poli, P. Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: A systematic review and meta-analysis. Mol. Psychiatry, 2022, 27(9), 3670-3678. doi: 10.1038/s41380-022-01611-w PMID: 35665763
- Salazar de Pablo, G.; Radua, J.; Pereira, J.; Bonoldi, I.; Arienti, V.; Besana, F.; Soardo, L.; Cabras, A.; Fortea, L.; Catalan, A.; Vaquerizo-Serrano, J.; Coronelli, F.; Kaur, S.; Da Silva, J.; Shin, J.I.; Solmi, M.; Brondino, N.; Politi, P.; McGuire, P.; Fusar-Poli, P. Probability of transition to psychosis in individuals at clinical high risk. JAMA Psychiatry, 2021, 78(9), 970-978. doi: 10.1001/jamapsychiatry.2021.0830 PMID: 34259821
- Fusar-Poli, P.; Cappucciati, M.; Borgwardt, S.; Woods, S.W.; Addington, J.; Nelson, B.; Nieman, D.H.; Stahl, D.R.; Rutigliano, G.; Riecher-Rössler, A.; Simon, A.E.; Mizuno, M.; Lee, T.Y.; Kwon, J.S.; Lam, M.M.L.; Perez, J.; Keri, S.; Amminger, P.; Metzler, S.; Kawohl, W.; Rössler, W.; Lee, J.; Labad, J.; Ziermans, T.; An, S.K.; Liu, C.C.; Woodberry, K.A.; Braham, A.; Corcoran, C.; McGorry, P.; Yung, A.R.; McGuire, P.K. Heterogeneity of psychosis risk within individuals at clinical high risk. JAMA Psychiatry, 2016, 73(2), 113-120. doi: 10.1001/jamapsychiatry.2015.2324 PMID: 26719911
- Provenzani, U.; Salazar de Pablo, G.; Arribas, M.; Pillmann, F.; Fusar-Poli, P. Clinical outcomes in brief psychotic episodes: A systematic review and meta-analysis. Epidemiol. Psychiatr. Sci., 2021, 30, e71. doi: 10.1017/S2045796021000548 PMID: 35698876
- Fusar-Poli, P.; Salazar de Pablo, G.; Rajkumar, R.P.; López-Díaz, Á.; Malhotra, S.; Heckers, S.; Lawrie, S.M.; Pillmann, F. Diagnosis, prognosis, and treatment of brief psychotic episodes: A review and research agenda. Lancet Psychiatry, 2022, 9(1), 72-83. doi: 10.1016/S2215-0366(21)00121-8 PMID: 34856200
- Minichino, A.; Rutigliano, G.; Merlino, S.; Davies, C.; Oliver, D.; De Micheli, A.; Patel, R.; McGuire, P.; Fusar-Poli, P. Unmet needs in patients with brief psychotic disorders: Too ill for clinical high risk services and not ill enough for first episode services. Eur. Psychiatry, 2019, 57, 26-32. doi: 10.1016/j.eurpsy.2018.12.006 PMID: 30658277
- Fusar-Poli, P.; Cappucciati, M.; De Micheli, A.; Rutigliano, G.; Bonoldi, I.; Tognin, S.; Ramella-Cravaro, V.; Castagnini, A.; McGuire, P. Diagnostic and prognostic significance of brief limited intermittent psychotic symptoms (BLIPS) in individuals at ultra high risk. Schizophr. Bull., 2017, 43(1), 48-56. doi: 10.1093/schbul/sbw151 PMID: 28053130
- Salazar de Pablo, G.; Besana, F.; Arienti, V.; Catalan, A.; Vaquerizo-Serrano, J.; Cabras, A.; Pereira, J.; Soardo, L.; Coronelli, F.; Kaur, S.; da Silva, J.; Oliver, D.; Petros, N.; Moreno, C.; Gonzalez-Pinto, A.; Díaz-Caneja, C.M.; Shin, J.I.; Politi, P.; Solmi, M.; Borgatti, R.; Mensi, M.M.; Arango, C.; Correll, C.U.; McGuire, P.; Fusar-Poli, P. Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: A meta-analysis. EClinicalMedicine, 2021, 36, 100909. doi: 10.1016/j.eclinm.2021.100909 PMID: 34189444
- Salazar de Pablo, G.; Soardo, L.; Cabras, A.; Pereira, J.; Kaur, S.; Besana, F.; Arienti, V.; Coronelli, F.; Shin, J.I.; Solmi, M.; Petros, N.; Carvalho, A.F.; McGuire, P.; Fusar-Poli, P. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: A meta-analysis. Epidemiol. Psychiatr. Sci., 2022, 31, e9. doi: 10.1017/S2045796021000639 PMID: 35042573
- Salazar de Pablo, G.; Woods, S.W.; Drymonitou, G.; de Diego, H.; Fusar-Poli, P. Prevalence of individuals at clinical high-risk of psychosis in the general population and clinical samples: Systematic review and meta-analysis. Brain Sci., 2021, 11(11), 1544. doi: 10.3390/brainsci11111544 PMID: 34827543
- Dragioti, E.; Radua, J.; Solmi, M.; Arango, C.; Oliver, D.; Cortese, S.; Jones, P.B.; Il Shin, J.; Correll, C.U.; Fusar-Poli, P. Global population attributable fraction of potentially modifiable risk factors for mental disorders: A meta-umbrella systematic review. Mol. Psychiatry, 2022, 27(8), 3510-3519. doi: 10.1038/s41380-022-01586-8 PMID: 35484237
- Perkins, D.O. Evaluating and treating the prodromal stage of schizophrenia. Curr. Psychiatry Rep., 2004, 6(4), 289-295. doi: 10.1007/s11920-004-0079-8 PMID: 15260945
- Häfner, H.; Riecher-Rössler, A.; Maurer, K.; Fätkenheuer, B.; Löffler, W. First onset and early symptomatology of schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci., 1992, 242(2-3), 109-118. doi: 10.1007/BF02191557 PMID: 1486099
- Norman, R.M.G.; Malla, A.K. Prodromal symptoms of relapse in schizophrenia: A review. Schizophr. Bull., 1995, 21(4), 527-539. doi: 10.1093/schbul/21.4.527 PMID: 8749881
- Yung, A.R.; McGorry, P.D. The initial prodrome in psychosis: Descriptive and qualitative aspects. Aust. N. Z. J. Psychiatry, 1996, 30(5), 587-599. doi: 10.3109/00048679609062654 PMID: 8902166
- Millan, M.J.; Andrieux, A.; Bartzokis, G.; Cadenhead, K.; Dazzan, P.; Fusar-Poli, P.; Gallinat, J.; Giedd, J.; Grayson, D.R.; Heinrichs, M.; Kahn, R.; Krebs, M.O.; Leboyer, M.; Lewis, D.; Marin, O.; Marin, P.; Meyer-Lindenberg, A.; McGorry, P.; McGuire, P.; Owen, M.J.; Patterson, P.; Sawa, A.; Spedding, M.; Uhlhaas, P.; Vaccarino, F.; Wahlestedt, C.; Weinberger, D. Altering the course of schizophrenia: progress and perspectives. Nat. Rev. Drug Discov., 2016, 15(7), 485-515. doi: 10.1038/nrd.2016.28 PMID: 26939910
- Psychosis and schizophrenia in adults: prevention and management. In: NICE Clinical Guidelines; National Institute for Health and Care Excellence (NICE): London, 2014.
- Fusar-Poli, P.; Borgwardt, S.; Bechdolf, A.; Addington, J.; Riecher-Rössler, A.; Schultze-Lutter, F.; Keshavan, M.; Wood, S.; Ruhrmann, S.; Seidman, L.J.; Valmaggia, L.; Cannon, T.; Velthorst, E.; De Haan, L.; Cornblatt, B.; Bonoldi, I.; Birchwood, M.; McGlashan, T.; Carpenter, W.; McGorry, P.; Klosterkötter, J.; McGuire, P.; Yung, A. The psychosis high-risk state: A comprehensive state-of-the-art review. JAMA Psychiatry, 2013, 70(1), 107-120. doi: 10.1001/jamapsychiatry.2013.269 PMID: 23165428
- Perkins, D.O.; Gu, H.; Boteva, K.; Lieberman, J.A. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis. Am. J. Psychiatry, 2005, 162(10), 1785-1804. doi: 10.1176/appi.ajp.162.10.1785 PMID: 16199825
- Altamura, A.C.; Serati, M.; Buoli, M. Is duration of illness really influencing outcome in major psychoses? Nord. J. Psychiatry, 2015, 69(6), 1685-1699. doi: 10.3109/08039488.2014.990919 PMID: 25768662
- Penttilä, M.; Jääskeläinen, E.; Hirvonen, N.; Isohanni, M.; Miettunen, J. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: Sstematic review and meta-analysis. Br. J. Psychiatry, 2014, 205(2), 88-94. doi: 10.1192/bjp.bp.113.127753 PMID: 25252316
- Boonstra, N.; Klaassen, R.; Sytema, S.; Marshall, M.; De Haan, L.; Wunderink, L.; Wiersma, D. Duration of untreated psychosis and negative symptoms A systematic review and meta-analysis of individual patient data. Schizophr. Res., 2012, 142(1-3), 12-19. doi: 10.1016/j.schres.2012.08.017 PMID: 23025994
- Singh, S.P. Outcome measures in early psychosis. Br. J. Psychiatry, 2007, 191(S50), s58-s63. doi: 10.1192/bjp.191.50.s58 PMID: 18019046
- Cuesta, M.J.; García de Jalón, E.; Campos, M.S.; Ibáñez, B.; Sánchez-Torres, A.M.; Peralta, V. Duration of untreated negative and positive symptoms of psychosis and cognitive impairment in first episode psychosis. Schizophr. Res., 2012, 141(2-3), 222-227. doi: 10.1016/j.schres.2012.08.019 PMID: 22989921
- Schimmelmann, B.G.; Huber, C.G.; Lambert, M.; Cotton, S.; McGorry, P.D.; Conus, P. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. J. Psychiatr. Res., 2008, 42(12), 982-990. doi: 10.1016/j.jpsychires.2007.12.001 PMID: 18199456
- Marshall, M.; Lewis, S.; Lockwood, A.; Drake, R.; Jones, P.; Croudace, T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: A systematic review. Arch. Gen. Psychiatry, 2005, 62(9), 975-983. doi: 10.1001/archpsyc.62.9.975 PMID: 16143729
- Oliver, D.; Davies, C.; Crossland, G.; Lim, S.; Gifford, G.; McGuire, P.; Fusar-Poli, P. Can we reduce the duration of untreated psychosis? a systematic review and meta-analysis of controlled interventional studies. Schizophr. Bull., 2018, 44(6), 1362-1372. doi: 10.1093/schbul/sbx166 PMID: 29373755
- Howes, O.D.; Whitehurst, T.; Shatalina, E.; Townsend, L.; Onwordi, E.C.; Mak, T.L.A.; Arumuham, A.; OBrien, O.; Lobo, M.; Vano, L.; Zahid, U.; Butler, E.; Osugo, M. The clinical significance of duration of untreated psychosis: An umbrella review and random‐effects meta‐analysis. World Psychiatry, 2021, 20(1), 75-95. doi: 10.1002/wps.20822 PMID: 33432766
- van Os, J. Salience syndrome replaces schizophrenia in DSM-V and ICD-11: psychiatrys evidence-based entry into the 21st century? Acta Psychiatr. Scand., 2009, 120(5), 363-372. doi: 10.1111/j.1600-0447.2009.01456.x PMID: 19807717
- van Os, J.; Hanssen, M.; Bijl, R.V.; Ravelli, A. Strauss (1969) revisited: A psychosis continuum in the general population? Schizophr. Res., 2000, 45(1-2), 11-20. doi: 10.1016/S0920-9964(99)00224-8 PMID: 10978868
- van Os, J.; Linscott, R.J. Introduction: The extended psychosis phenotype-relationship with schizophrenia and with ultrahigh risk status for psychosis. Schizophr. Bull., 2012, 38(2), 227-230. doi: 10.1093/schbul/sbr188 PMID: 22355185
- Staines, L.; Healy, C.; Coughlan, H.; Clarke, M.; Kelleher, I.; Cotter, D.; Cannon, M. Psychotic experiences in the general population, a review; definition, risk factors, outcomes and interventions. Psychol. Med., 2022, 52(15), 3297-3308. doi: 10.1017/S0033291722002550 PMID: 36004805
- Fusar-Poli, P.; Raballo, A.; Parnas, J. What is an attenuated psychotic symptom? on the importance of the context. Schizophr. Bull., 2017, 43(4), 687-692. PMID: 28039421
- Linscott, R.J.; van Os, J. An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: On the pathway from proneness to persistence to dimensional expression across mental disorders. Psychol. Med., 2012, 1-17. PMID: 22850401
- McGrath, J.J.; Saha, S.; Al-Hamzawi, A.; Alonso, J.; Bromet, E.J.; Bruffaerts, R.; Caldas-de-Almeida, J.M.; Chiu, W.T.; de Jonge, P.; Fayyad, J.; Florescu, S.; Gureje, O.; Haro, J.M.; Hu, C.; Kovess-Masfety, V.; Lepine, J.P.; Lim, C.C.W.; Mora, M.E.M.; Navarro-Mateu, F.; Ochoa, S.; Sampson, N.; Scott, K.; Viana, M.C.; Kessler, R.C. Psychotic experiences in the general population. JAMA Psychiatry, 2015, 72(7), 697-705. doi: 10.1001/jamapsychiatry.2015.0575 PMID: 26018466
- Kelleher, I.; Connor, D.; Clarke, M.C.; Devlin, N.; Harley, M.; Cannon, M. Prevalence of psychotic symptoms in childhood and adolescence: A systematic review and meta-analysis of population-based studies. Psychol. Med., 2012, 42(9), 1857-1863. doi: 10.1017/S0033291711002960 PMID: 22225730
- De Loore, E.; Gunther, N.; Drukker, M.; Feron, F.; Sabbe, B.; Deboutte, D.; van Os, J.; Myin-Germeys, I. Persistence and outcome of auditory hallucinations in adolescence: A longitudinal general population study of 1800 individuals. Schizophr. Res., 2011, 127(1-3), 252-256. doi: 10.1016/j.schres.2011.01.015 PMID: 21315559
- Dominguez, M.D.G.; Wichers, M.; Lieb, R.; Wittchen, H.U.; van Os, J. Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr. Bull., 2011, 37(1), 84-93. doi: 10.1093/schbul/sbp022 PMID: 19460881
- Downs, J.M.; Cullen, A.E.; Barragan, M.; Laurens, K.R. Persisting psychotic-like experiences are associated with both externalising and internalising psychopathology in a longitudinal general population child cohort. Schizophr. Res., 2013, 144(1-3), 99-104. doi: 10.1016/j.schres.2012.12.009 PMID: 23321428
- Thapar, A.; Heron, J.; Jones, R.B.; Owen, M.J.; Lewis, G.; Zammit, S. Trajectories of change in self-reported psychotic-like experiences in childhood and adolescence. Schizophr. Res., 2012, 140(1-3), 104-109. doi: 10.1016/j.schres.2012.06.024 PMID: 22789670
- Healy, C.; Brannigan, R.; Dooley, N.; Coughlan, H.; Clarke, M.; Kelleher, I.; Cannon, M. Childhood and adolescent psychotic experiences and risk of mental disorder: A systematic review and meta-analysis. Psychol. Med., 2019, 49(10), 1589-1599. doi: 10.1017/S0033291719000485 PMID: 31088578
- Yates, K.; Lång, U.; Cederlöf, M.; Boland, F.; Taylor, P.; Cannon, M.; McNicholas, F.; DeVylder, J.; Kelleher, I. Association of psychotic experiences with subsequent risk of suicidal ideation, suicide attempts, and suicide deaths. JAMA Psychiatry, 2019, 76(2), 180-189. doi: 10.1001/jamapsychiatry.2018.3514 PMID: 30484818
- Schultze-Lutter, F.; Renner, F.; Paruch, J.; Julkowski, D.; Klosterkötter, J.; Ruhrmann, S. Self-reported psychotic-like experiences are a poor estimate of clinician-rated attenuated and frank delusions and hallucinations. Psychopathology, 2014, 47(3), 194-201. doi: 10.1159/000355554 PMID: 24192655
- Varese, F.; Smeets, F.; Drukker, M.; Lieverse, R.; Lataster, T.; Viechtbauer, W.; Read, J.; van Os, J.; Bentall, R.P. Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr. Bull., 2012, 38(4), 661-671. doi: 10.1093/schbul/sbs050 PMID: 22461484
- Radua, J.; Ramella-Cravaro, V.; Ioannidis, J.P.A.; Reichenberg, A.; Phiphopthatsanee, N.; Amir, T.; Yenn Thoo, H.; Oliver, D.; Davies, C.; Morgan, C.; McGuire, P.; Murray, R.M.; Fusar-Poli, P. What causes psychosis? An umbrella review of risk and protective factors. World Psychiatry, 2018, 17(1), 49-66. doi: 10.1002/wps.20490 PMID: 29352556
- Pastore, A.; de Girolamo, G.; Tafuri, S.; Tomasicchio, A.; Margari, F. Traumatic experiences in childhood and adolescence: A meta-analysis of prospective studies assessing risk for psychosis. Eur. Child Adolesc. Psychiatry, 2022, 31(2), 215-228. doi: 10.1007/s00787-020-01574-9 PMID: 32577908
- Davies, C.; Segre, G.; Estradé, A.; Radua, J.; De Micheli, A.; Provenzani, U.; Oliver, D.; Salazar de Pablo, G.; Ramella-Cravaro, V.; Besozzi, M.; Dazzan, P.; Miele, M.; Caputo, G.; Spallarossa, C.; Crossland, G.; Ilyas, A.; Spada, G.; Politi, P.; Murray, R.M.; McGuire, P.; Fusar-Poli, P. Prenatal and perinatal risk and protective factors for psychosis: A systematic review and meta-analysis. Lancet Psychiatry, 2020, 7(5), 399-410. doi: 10.1016/S2215-0366(20)30057-2 PMID: 32220288
- Arango, C.; Dragioti, E.; Solmi, M.; Cortese, S.; Domschke, K.; Murray, R.M.; Jones, P.B.; Uher, R.; Carvalho, A.F.; Reichenberg, A.; Shin, J.I.I.; Andreassen, O.A.; Correll, C.U.; Fusar-Poli, P. Risk and protective factors for mental disorders beyond genetics: An evidence‐based atlas. World Psychiatry, 2021, 20(3), 417-436. doi: 10.1002/wps.20894 PMID: 34505386
- Pignon, B.; Lajnef, M.; Kirkbride, J.B.; Peyre, H.; Ferchiou, A.; Richard, J.R.; Baudin, G.; Tosato, S.; Jongsma, H.; de Haan, L.; Tarricone, I.; Bernardo, M.; Velthorst, E.; Braca, M.; Arango, C.; Arrojo, M.; Bobes, J.; Del-Ben, C.M.; Di Forti, M.; Gayer-Anderson, C.; Jones, P.B.; La Cascia, C.; Lasalvia, A.; Menezes, P.R.; Quattrone, D.; Sanjuán, J.; Selten, J.P.; Tortelli, A.; Llorca, P.M.; van Os, J.; Rutten, B.P.F.; Murray, R.M.; Morgan, C.; Leboyer, M.; Szöke, A.; Schürhoff, F. The independent effects of psychosocial stressors on subclinical psychosis: Findings from the multinational EU-GEI study. Schizophr. Bull., 2021, 47(6), 1674-1684. doi: 10.1093/schbul/sbab060 PMID: 34009318
- Fusar-Poli, P.; Tantardini, M.; De Simone, S.; Ramella-Cravaro, V.; Oliver, D.; Kingdon, J.; Kotlicka-Antczak, M.; Valmaggia, L.; Lee, J.; Millan, M.J.; Galderisi, S.; Balottin, U.; Ricca, V.; McGuire, P. Deconstructing vulnerability for psychosis: Meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk. Eur. Psychiatry, 2017, 40, 65-75. doi: 10.1016/j.eurpsy.2016.09.003 PMID: 27992836
- Kraan, T.C.; Ising, H.K.; Fokkema, M.; Velthorst, E.; van den Berg, D.P.G.; Kerkhoven, M.; Veling, W.; Smit, F.; Linszen, D.H.; Nieman, D.H.; Wunderink, L.; Boonstra, N.; Klaassen, R.M.C.; Dragt, S.; Rietdijk, J.; de Haan, L.; van der Gaag, M. The effect of childhood adversity on 4-year outcome in individuals at ultra high risk for psychosis in the dutch early detection intervention evaluation (EDIE-NL) trial. Psychiatry Res., 2017, 247, 55-62. doi: 10.1016/j.psychres.2016.11.014 PMID: 27863320
- Kraan, T.C.; Velthorst, E.; Themmen, M.; Valmaggia, L.; Kempton, M.J.; McGuire, P.; van Os, J.; Rutten, B.P.F.; Smit, F.; de Haan, L.; van der Gaag, M.; Study, E.U.G.E.I.H.R. Child maltreatment and clinical outcome in individuals at ultra-high risk for psychosis in the EU-GEI high risk study. Schizophr. Bull., 2018, 44(3), 584-592. doi: 10.1093/schbul/sbw162 PMID: 28666366
- Peh, O.H.; Rapisarda, A.; Lee, J. Childhood adversities in people at ultra-high risk (UHR) for psychosis: A systematic review and meta-analysis. Psychol. Med., 2019, 49(7), 1089-1101. doi: 10.1017/S003329171800394X PMID: 30616701
- Liu, Y.; Mendonça, M.; Cannon, M.; Jones, P.B.; Lewis, G.; Thompson, A.; Zammit, S.; Wolke, D. Testing the independent and joint contribution of exposure to neurodevelopmental adversity and childhood trauma to risk of psychotic experiences in adulthood. Schizophr. Bull., 2021, 47(3), 776-784. doi: 10.1093/schbul/sbaa174 PMID: 33331643
- Lataster, J.; Myin-Germeys, I.; Lieb, R.; Wittchen, H.U.; van Os, J. Adversity and psychosis: A 10-year prospective study investigating synergism between early and recent adversity in psychosis. Acta Psychiatr. Scand., 2012, 125(5), 388-399. doi: 10.1111/j.1600-0447.2011.01805.x PMID: 22128839
- Brown, G.W.; Birley, J.L.T. Crises and life changes and the onset of schizophrenia. J. Health Soc. Behav., 1968, 9(3), 203-214. doi: 10.2307/2948405 PMID: 5676853
- Beards, S.; Gayer-Anderson, C.; Borges, S.; Dewey, M.E.; Fisher, H.L.; Morgan, C. Life events and psychosis: A review and meta-analysis. Schizophr. Bull., 2013, 39(4), 740-747. doi: 10.1093/schbul/sbt065 PMID: 23671196
- Cullen, A.E.; Fisher, H.L.; Roberts, R.E.; Pariante, C.M.; Laurens, K.R. Daily stressors and negative life events in children at elevated risk of developing schizophrenia. Br. J. Psychiatry, 2014, 204(5), 354-360. doi: 10.1192/bjp.bp.113.127001 PMID: 24627296
- Trotman, H.D.; Holtzman, C.W.; Walker, E.F.; Addington, J.M.; Bearden, C.E.; Cadenhead, K.S.; Cannon, T.D.; Cornblatt, B.A.; Heinssen, R.K.; Mathalon, D.H.; Tsuang, M.T.; Perkins, D.O.; Seidman, L.J.; Woods, S.W.; McGlashan, T.H. Stress exposure and sensitivity in the clinical high-risk syndrome: Initial findings from the North American Prodrome Longitudinal Study (NAPLS). Schizophr. Res., 2014, 160(1-3), 104-109. doi: 10.1016/j.schres.2014.09.017 PMID: 25443665
- Cullen, A.E.; Addington, J.; Bearden, C.E.; Stone, W.S.; Seidman, L.J.; Cadenhead, K.S.; Cannon, T.D.; Cornblatt, B.A.; Mathalon, D.H.; McGlashan, T.H.; Perkins, D.O.; Tsuang, M.T.; Woods, S.W.; Walker, E.F. Stressor-cortisol concordance among individuals at clinical high-risk for psychosis: Novel findings from the NAPLS cohort. Psychoneuroendocrinology, 2020, 115, 104649. doi: 10.1016/j.psyneuen.2020.104649 PMID: 32197198
- Cannon, T.D.; Yu, C.; Addington, J.; Bearden, C.E.; Cadenhead, K.S.; Cornblatt, B.A.; Heinssen, R.; Jeffries, C.D.; Mathalon, D.H.; McGlashan, T.H.; Perkins, D.O.; Seidman, L.J.; Tsuang, M.T.; Walker, E.F.; Woods, S.W.; Kattan, M.W. An individualized risk calculator for research in prodromal psychosis. Am. J. Psychiatry, 2016, 173(10), 980-988. doi: 10.1176/appi.ajp.2016.15070890 PMID: 27363508
- Solhan, M.B.; Trull, T.J.; Jahng, S.; Wood, P.K. Clinical assessment of affective instability: Comparing EMA indices, questionnaire reports, and retrospective recall. Psychol. Assess., 2009, 21(3), 425-436. doi: 10.1037/a0016869 PMID: 19719353
- Larson, R.; Csikszentmihalyi, M. The experience sampling method. In: Flow and the Foundations of Positive Psychology; Springer: Dordrecht, 2014. doi: 10.1007/978-94-017-9088-8_2
- Shiffman, S.; Stone, A.A.; Hufford, M.R. Ecological momentary assessment. Annu. Rev. Clin. Psychol., 2008, 4(1), 1-32. doi: 10.1146/annurev.clinpsy.3.022806.091415 PMID: 18509902
- Wright, A.C.; Browne, J.; Skiest, H.; Bhiku, K.; Baker, J.T.; Cather, C. The relationship between conventional clinical assessments and momentary assessments of symptoms and functioning in schizophrenia spectrum disorders: A systematic review. Schizophr. Res., 2021, 232, 11-27. doi: 10.1016/j.schres.2021.04.010 PMID: 34004382
- Bell, I.H.; Lim, M.H.; Rossell, S.L.; Thomas, N. Ecological momentary assessment and intervention in the treatment of psychotic disorders: A systematic review. Psychiatr. Serv., 2017, 68(11), 1172-1181. doi: 10.1176/appi.ps.201600523 PMID: 28669284
- Myin-Germeys, I.; van Os, J.; Schwartz, J.E.; Stone, A.A.; Delespaul, P.A. Emotional reactivity to daily life stress in psychosis. Arch. Gen. Psychiatry, 2001, 58(12), 1137-1144. doi: 10.1001/archpsyc.58.12.1137 PMID: 11735842
- Myin-Germeys, I.; Delespaul, P.H.; Van Os, J. Behavioural sensitization to daily life stress in psychosis. Psychol. Med., 2005, 35(5), 733-741. doi: 10.1017/S0033291704004179 PMID: 15918350
- Palmier-Claus, J.E.; Dunn, G.; Lewis, S.W. Emotional and symptomatic reactivity to stress in individuals at ultra-high risk of developing psychosis. Psychol. Med., 2012, 42(5), 1003-1012. doi: 10.1017/S0033291711001929 PMID: 22067414
- Paetzold, I.; Myin-Germeys, I.; Schick, A.; Nelson, B.; Velthorst, E.; Schirmbeck, F.; van Os, J.; Morgan, C.; Hartmann, J.; van der Gaag, M.; de Haan, L.; Valmaggia, L.; McGuire, P.; Kempton, M.; Reininghaus, U. Stress reactivity as a putative mechanism linking childhood trauma with clinical outcomes in individuals at ultra-high-risk for psychosis: Findings from the EU-GEI High Risk Study. Epidemiol. Psychiatr. Sci., 2021, 30, e40. doi: 10.1017/S2045796021000251 PMID: 34044905
- Collip, D.; Wigman, J.T.W.; Myin-Germeys, I.; Jacobs, N.; Derom, C.; Thiery, E.; Wichers, M.; van Os, J. From epidemiology to daily life: linking daily life stress reactivity to persistence of psychotic experiences in a longitudinal general population study. PLoS One, 2013, 8(4), e62688. doi: 10.1371/journal.pone.0062688 PMID: 23626848
- Anglin, D.M.; Ereshefsky, S.; Klaunig, M.J.; Bridgwater, M.A.; Niendam, T.A.; Ellman, L.M.; DeVylder, J.; Thayer, G.; Bolden, K.; Musket, C.W.; Grattan, R.E.; Lincoln, S.H.; Schiffman, J.; Lipner, E.; Bachman, P.; Corcoran, C.M.; Mota, N.B.; van der Ven, E. From womb to neighborhood: A racial analysis of social determinants of psychosis in the United States. Am. J. Psychiatry, 2021, 178(7), 599-610. doi: 10.1176/appi.ajp.2020.20071091 PMID: 33934608
- Betancourt, T.S.; Newnham, E.A.; Birman, D.; Lee, R.; Ellis, B.H.; Layne, C.M. Comparing trauma exposure, mental health needs, and service utilization across clinical samples of refugee, immigrant, and u.s.-origin children. J. Trauma. Stress, 2017, 30(3), 209-218. doi: 10.1002/jts.22186 PMID: 28585740
- Eisenman, D.P.; Gelberg, L.; Liu, H.; Shapiro, M.F. Mental health and health-related quality of life among adult Latino primary care patients living in the United States with previous exposure to political violence. JAMA, 2003, 290(5), 627-634. doi: 10.1001/jama.290.5.627 PMID: 12902366
- Cleary, S.D.; Snead, R.; Dietz-Chavez, D.; Rivera, I.; Edberg, M.C. Immigrant trauma and mental health outcomes among latino youth. J. Immigr. Minor. Health, 2018, 20(5), 1053-1059. doi: 10.1007/s10903-017-0673-6 PMID: 29139024
- Lopez, D.; Altamirano, O.; Weisman de Mamani, A. The association between perceived racial discrimination and subclinical symptoms of psychosis. J. Ment. Health, 2022, 31(1), 14-21. doi: 10.1080/09638237.2020.1793120 PMID: 32662709
- Fusar-Poli, P.; Rutigliano, G.; Stahl, D.; Schmidt, A.; Ramella-Cravaro, V.; Hitesh, S.; McGuire, P. Deconstructing pretest risk enrichment to optimize prediction of psychosis in individuals at clinical high risk. JAMA Psychiatry, 2016, 73(12), 1260-1267. doi: 10.1001/jamapsychiatry.2016.2707 PMID: 27784037
- Oliver, D.; Reilly, T.J.; Baccaredda Boy, O.; Petros, N.; Davies, C.; Borgwardt, S.; McGuire, P.; Fusar-Poli, P. What causes the onset of psychosis in individuals at clinical high risk? a meta-analysis of risk and protective factors. Schizophr. Bull., 2022, 46(1), 110-120. PMID: 31219164
- Thompson, J.L.; Kelly, M.; Kimhy, D.; Harkavy-Friedman, J.M.; Khan, S.; Messinger, J.W.; Schobel, S.; Goetz, R.; Malaspina, D.; Corcoran, C. Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis. Schizophr. Res., 2009, 108(1-3), 176-181. doi: 10.1016/j.schres.2008.12.005 PMID: 19174322
- Geros, H.; Sizer, H.; Mifsud, N.; Reynolds, S.; Kim, D.J.; Eaton, S.; McGorry, P.; Nelson, B.; ODonoghue, B. Migrant status and identification as ultra‐high risk for psychosis and transitioning to a psychotic disorder. Acta Psychiatr. Scand., 2020, 141(1), 52-59. doi: 10.1111/acps.13099 PMID: 31520527
- Moore, D.; Castagnini, E.; Mifsud, N.; Geros, H.; Sizer, H.; Addington, J.; van der Gaag, M.; Nelson, B.; McGorry, P.; ODonoghue, B. The associations between migrant status and ethnicity and the identification of individuals at ultra-high risk for psychosis and transition to psychosis: A systematic review. Soc. Psychiatry Psychiatr. Epidemiol., 2021, 56(11), 1923-1941. doi: 10.1007/s00127-021-02047-3 PMID: 33641006
- Nerhus, M.; Berg, A.O.; Haram, M.; Kvitland, L.R.; Andreassen, O.A.; Melle, I. Migrant background and ethnic minority status as predictors for duration of untreated psychosis. Early Interv. Psychiatry, 2015, 9(1), 61-65. doi: 10.1111/eip.12106 PMID: 24225002
- Boonstra, N.; Sterk, B.; Wunderink, L.; Sytema, S.; De Haan, L.; Wiersma, D. Association of treatment delay, migration and urbanicity in psychosis. Eur. Psychiatry, 2012, 27(7), 500-505. doi: 10.1016/j.eurpsy.2011.05.001 PMID: 21705200
- Lindert, J.; Schouler-Ocak, M.; Heinz, A.; Priebe, S. Mental health, health care utilisation of migrants in Europe. Eur. Psychiatry, 2008, 23(S1), s114-s20. doi: 10.1016/S0924-9338(08)70057-9 PMID: 18371575
- Jensen, N.K.; Norredam, M.; Priebe, S.; Krasnik, A. How do general practitioners experience providing care to refugees with mental health problems? A qualitative study from Denmark. BMC Fam. Pract., 2013, 14(1), 17. doi: 10.1186/1471-2296-14-17 PMID: 23356401
- Vargas, T.; Damme, K.S.F.; Osborne, K.J.; Mittal, V.A. Differentiating kinds of systemic stressors with relation to psychotic-like experiences in late childhood and early adolescence: the stimulation, discrepancy, and deprivation model of psychosis. Clin. Psychol. Sci., 2022, 10(2), 291-309. doi: 10.1177/21677026211016415 PMID: 35402089
- Robinson, T.; Ali, M.U.; Easterbrook, B.; Hall, W.; Jutras-Aswad, D.; Fischer, B. Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: A systematic review and meta-analysis. Psychol. Med., 2022, 1-11. doi: 10.1017/S0033291722000502 PMID: 35321777
- Orsolini, L.; Chiappini, S.; Papanti, D.; De Berardis, D.; Corkery, J.M.; Schifano, F. The bridge between classical and "synthetic"/chemical psychoses: Towards a clinical, psychopathological, and therapeutic perspective. Front. Psychiatry, 2019, 10, 851. doi: 10.3389/fpsyt.2019.00851 PMID: 31849723
- Hjorthøj, C.; Larsen, M.O.; Starzer, M.S.K.; Nordentoft, M. Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016. Psychol. Med., 2021, 51(4), 617-622. doi: 10.1017/S0033291719003532 PMID: 31839011
- Rognli, E.B.; Taipale, H.; Hjorthøj, C.; Mittendorfer-Rutz, E.; Bramness, J.G.; Heiberg, I.H.; Niemelä, S. Annual incidence of substance-induced psychoses in Scandinavia from 2000 to 2016. Psychol. Med., 2022, 1-10. doi: 10.1017/S003329172200229X PMID: 35983644
- De Berardis, D.; De Filippis, S.; Masi, G.; Vicari, S.; Zuddas, A. A neurodevelopment approach for a transitional model of early onset schizophrenia. Brain Sci., 2021, 11(2), 275. doi: 10.3390/brainsci11020275 PMID: 33672396
- van der Steur, S.J.; Batalla, A.; Bossong, M.G. Factors moderating the association between cannabis use and psychosis risk: A systematic review. Brain Sci., 2020, 10(2), 97. doi: 10.3390/brainsci10020097 PMID: 32059350
- Barzilay, R.; Pries, L.K.; Moore, T.M.; Gur, R.E.; van Os, J.; Rutten, B.P.F.; Guloksuz, S. Exposome and trans-syndromal developmental trajectories toward psychosis. Biol. Psychiatry Global Open Sci., 2022, 2(3), 197-205. doi: 10.1016/j.bpsgos.2022.05.001 PMID: 36325037
- Cougnard, A.; Marcelis, M.; Myin-Germeys, I.; De Graaf, R.; Vollebergh, W.; Krabbendam, L.; Lieb, R.; Wittchen, H.U.; Henquet, C.; Spauwen, J.; Van Os, J. Does normal developmental expression of psychosis combine with environmental risk to cause persistence of psychosis? A psychosis pronenesspersistence model. Psychol. Med., 2007, 37(4), 513-527. doi: 10.1017/S0033291706009731 PMID: 17288646
- Carlyle, M.; Constable, T.; Walter, Z.C.; Wilson, J.; Newland, G.; Hides, L. Cannabis-induced dysphoria/paranoia mediates the link between childhood trauma and psychotic-like experiences in young cannabis users. Schizophr. Res., 2021, 238, 178-184. doi: 10.1016/j.schres.2021.10.011 PMID: 34717186
- Harley, M.; Kelleher, I.; Clarke, M.; Lynch, F.; Arseneault, L.; Connor, D.; Fitzpatrick, C.; Cannon, M. Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence. Psychol. Med., 2010, 40(10), 1627-1634. doi: 10.1017/S0033291709991966 PMID: 19995476
- Day, F.; Pariante, C.M. Stress and cortisol in the pre-psychotic phases.Vulnerability to psychosis: from neurosciences to psychopathology Fusar-Poli, P.; Borgwardt, S.; McGuire, P., Eds.; Psychology Press: Hove, East Sussex ; , 2012.
- Krugers, H.J.; Karst, H.; Joels, M. Interactions between noradrenaline and corticosteroids in the brain: from electrical activity to cognitive performance. Front. Cell. Neurosci., 2012, 6, 15. doi: 10.3389/fncel.2012.00015 PMID: 22509154
- Laryea, G.; Schütz, G.; Muglia, L.J. Disrupting hypothalamic glucocorticoid receptors causes HPA axis hyperactivity and excess adiposity. Mol. Endocrinol., 2013, 27(10), 1655-1665. doi: 10.1210/me.2013-1187 PMID: 23979842
- Pariante, C.M. Pituitary volume in psychosis: the first review of the evidence. J. Psychopharmacol., 2008, 22(S2), 76-81. doi: 10.1177/0269881107084020 PMID: 18709702
- Zipursky, A.R.; Whittle, S.; Yücel, M.; Lorenzetti, V.; Wood, S.J.; Lubman, D.I.; Simmons, J.G.; Allen, N.B. Pituitary volume prospectively predicts internalizing symptoms in adolescence. J. Child Psychol. Psychiatry, 2011, 52(3), 315-323. doi: 10.1111/j.1469-7610.2010.02337.x PMID: 21073460
- Girshkin, L.; Matheson, S.L.; Shepherd, A.M.; Green, M.J. Morning cortisol levels in schizophrenia and bipolar disorder: A meta-analysis. Psychoneuroendocrinology, 2014, 49, 187-206. doi: 10.1016/j.psyneuen.2014.07.013 PMID: 25108162
- Misiak, B.; Pruessner, M.; Samochowiec, J.; Wiśniewski, M.; Reginia, A.; Stańczykiewicz, B. A meta-analysis of blood and salivary cortisol levels in first-episode psychosis and high-risk individuals. Front. Neuroendocrinol., 2021, 62, 100930. doi: 10.1016/j.yfrne.2021.100930 PMID: 34171354
- Hubbard, D.B.; Miller, B.J. Meta-analysis of blood cortisol levels in individuals with first-episode psychosis. Psychoneuroendocrinology, 2019, 104, 269-275. doi: 10.1016/j.psyneuen.2019.03.014 PMID: 30909008
- Ciufolini, S.; Dazzan, P.; Kempton, M.J.; Pariante, C.; Mondelli, V. HPA axis response to social stress is attenuated in schizophrenia but normal in depression: Evidence from a meta-analysis of existing studies. Neurosci. Biobehav. Rev., 2014, 47, 359-368. doi: 10.1016/j.neubiorev.2014.09.004 PMID: 25246294
- Zorn, J.V.; Schür, R.R.; Boks, M.P.; Kahn, R.S.; Joëls, M.; Vinkers, C.H. Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis. Psychoneuroendocrinology, 2017, 77, 25-36. doi: 10.1016/j.psyneuen.2016.11.036 PMID: 28012291
- Berger, M.; Kraeuter, A.K.; Romanik, D.; Malouf, P.; Amminger, G.P.; Sarnyai, Z. Cortisol awakening response in patients with psychosis: Systematic review and meta-analysis. Neurosci. Biobehav. Rev., 2016, 68, 157-166. doi: 10.1016/j.neubiorev.2016.05.027 PMID: 27229759
- Dauvermann, M.R.; Donohoe, G. Cortisol stress response in psychosis from the high-risk to the chronic stage: A systematic review. Ir. J. Psychol. Med., 2019, 36(4), 305-315. doi: 10.1017/ipm.2019.27 PMID: 31317845
- Andrade, E.H.; Rizzo, L.B.; Noto, C.; Ota, V.K.; Gadelha, A.; Daruy-Filho, L.; Tasso, B.C.; Mansur, R.B.; Cordeiro, Q.; Belangero, S.I.; Bressan, R.A.; Grassi-Oliveira, R.; Brietzke, E. Hair cortisol in drug-naïve first-episode individuals with psychosis. Rev. Bras. Psiquiatr., 2016, 38(1), 11-16. doi: 10.1590/1516-4446-2014-1634 PMID: 26814837
- van den Heuvel, L.L.; Smit, A.M.; Stalder, T.; Kirschbaum, C.; Seedat, S.; Emsley, R. Hair cortisol levels in schizophrenia and metabolic syndrome. Early Interv. Psychiatry, 2022, 16(8), 902-911. doi: 10.1111/eip.13238 PMID: 34978366
- Chaumette, B.; Kebir, O.; Mam-Lam-Fook, C.; Morvan, Y.; Bourgin, J.; Godsil, B.P.; Plaze, M.; Gaillard, R.; Jay, T.M.; Krebs, M.O. Salivary cortisol in early psychosis: New findings and meta-analysis. Psychoneuroendocrinology, 2016, 63, 262-270. doi: 10.1016/j.psyneuen.2015.10.007 PMID: 26520686
- Pruessner, M.; Béchard-Evans, L.; Boekestyn, L.; Iyer, S.N.; Pruessner, J.C.; Malla, A.K. Attenuated cortisol response to acute psychosocial stress in individuals at ultra-high risk for psychosis. Schizophr. Res., 2013, 146(1-3), 79-86. doi: 10.1016/j.schres.2013.02.019 PMID: 23510595
- Walter, E.E.; Fernandez, F.; Snelling, M.; Barkus, E. Stress induced cortisol release and schizotypy. Psychoneuroendocrinology, 2018, 89, 209-215. doi: 10.1016/j.psyneuen.2018.01.012 PMID: 29414034
- van Leeuwen, J.M.C.; Vink, M.; Fernández, G.; Hermans, E.J.; Joëls, M.; Kahn, R.S.; Vinkers, C.H. At-risk individuals display altered brain activity following stress. Neuropsychopharmacology, 2018, 43(9), 1954-1960. doi: 10.1038/s41386-018-0026-8 PMID: 29483659
- Heinze, K.; Lin, A.; Reniers, R.L.E.P.; Wood, S.J. Longer-term increased cortisol levels in young people with mental health problems. Psychiatry Res., 2016, 236, 98-104. doi: 10.1016/j.psychres.2015.12.025 PMID: 26749569
- Söder, E.; Clamor, A.; Lincoln, T.M. Hair cortisol concentrations as an indicator of potential HPA axis hyperactivation in risk for psychosis. Schizophr. Res., 2019, 212, 54-61. doi: 10.1016/j.schres.2019.08.012 PMID: 31455519
- Worthington, M.A.; Walker, E.F.; Addington, J.; Bearden, C.E.; Cadenhead, K.S.; Cornblatt, B.A.; Mathalon, D.H.; McGlashan, T.H.; Perkins, D.O.; Seidman, L.J.; Tsuang, M.T.; Woods, S.W.; Cannon, T.D. Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis. Schizophr. Res., 2021, 227, 95-100. doi: 10.1016/j.schres.2020.09.022 PMID: 33046334
- Cullen, A.E.; Fisher, H.L.; Gullet, N.; Fraser, E.R.; Roberts, R.E.; Zahid, U.; To, M.; Yap, N.H.; Zunszain, P.A.; Pariante, C.M.; Wood, S.J.; McGuire, P.; Murray, R.M.; Mondelli, V.; Laurens, K.R. Cortisol levels in childhood associated with emergence of attenuated psychotic symptoms in early adulthood. Biol. Psychiatry, 2022, 91(2), 226-235. doi: 10.1016/j.biopsych.2021.08.009 PMID: 34715990
- Nordholm, D.; Krogh, J.; Mondelli, V.; Dazzan, P.; Pariante, C.; Nordentoft, M. Pituitary gland volume in patients with schizophrenia, subjects at ultra high-risk of developing psychosis and healthy controls: A systematic review and meta-analysis. Psychoneuroendocrinology, 2013, 38(11), 2394-2404. doi: 10.1016/j.psyneuen.2013.06.030 PMID: 23890984
- Saunders, T.S.; Mondelli, V.; Cullen, A.E. Pituitary volume in individuals at elevated risk for psychosis: A systematic review and meta-analysis. Schizophr. Res., 2019, 213, 23-31. doi: 10.1016/j.schres.2018.12.026 PMID: 30600112
- Garner, B.; Pariante, C.M.; Wood, S.J.; Velakoulis, D.; Phillips, L.; Soulsby, B.; Brewer, W.J.; Smith, D.J.; Dazzan, P.; Berger, G.E.; Yung, A.R.; van den Buuse, M.; Murray, R.; McGorry, P.D.; Pantelis, C. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol. Psychiatry, 2005, 58(5), 417-423. doi: 10.1016/j.biopsych.2005.04.018 PMID: 16026767
- Cullen, A.E.; Rai, S.; Vaghani, M.S.; Mondelli, V.; McGuire, P. Cortisol responses to naturally occurring psychosocial stressors across the psychosis spectrum: A systematic review and meta-analysis. Front. Psychiatry, 2020, 11(11), 513. doi: 10.3389/fpsyt.2020.00513 PMID: 32595532
- Collip, D.; Nicolson, N.A.; Lardinois, M.; Lataster, T.; van Os, J.; Myin-Germeys, I. Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis. Psychol. Med., 2011, 41(11), 2305-2315. doi: 10.1017/S0033291711000602 PMID: 21733219
- Vaessen, T.; Kasanova, Z.; Hernaus, D.; Lataster, J.; Collip, D.; van Nierop, M.; Myin-Germeys, I. Overall cortisol, diurnal slope, and stress reactivity in psychosis: An experience sampling approach. Psychoneuroendocrinology, 2018, 96, 61-68. doi: 10.1016/j.psyneuen.2018.06.007 PMID: 29906787
- Leboyer, M.; Oliveira, J.; Tamouza, R.; Groc, L. Is it time for immunopsychiatry in psychotic disorders? Psychopharmacology, 2016, 233(9), 1651-1660. doi: 10.1007/s00213-016-4266-1 PMID: 26988846
- Zefferino, R.; Di Gioia, S.; Conese, M. Molecular links between endocrine, nervous and immune system during chronic stress. Brain Behav., 2021, 11(2), e01960. doi: 10.1002/brb3.1960 PMID: 33295155
- Mondelli, V. From stress to psychosis: Whom, how, when and why? Epidemiol. Psychiatr. Sci., 2014, 23(3), 215-218. doi: 10.1017/S204579601400033X PMID: 24905592
- Orsolini, L.; Sarchione, F.; Vellante, F.; Fornaro, M.; Matarazzo, I.; Martinotti, G.; Valchera, A.; Di Nicola, M.; Carano, A.; Di Giannantonio, M.; Perna, G.; Olivieri, L.; De Berardis, D. Protein-C reactive as biomarker predictor of schizophrenia phases of illness? a systematic review. Curr. Neuropharmacol., 2018, 16(5), 583-606. doi: 10.2174/1570159X16666180119144538 PMID: 29357805
- Heurich, M.; Föcking, M.; Mongan, D.; Cagney, G.; Cotter, D.R. Dysregulation of complement and coagulation pathways: Emerging mechanisms in the development of psychosis. Mol. Psychiatry, 2022, 27(1), 127-140. doi: 10.1038/s41380-021-01197-9 PMID: 34226666
- Al-Diwani, A.A.J.; Pollak, T.A.; Irani, S.R.; Lennox, B.R. Psychosis: An autoimmune disease? Immunology, 2017, 152(3), 388-401. doi: 10.1111/imm.12795 PMID: 28704576
- Choudhury, Z.; Lennox, B. Maternal immune activation and schizophreniaevidence for an immune priming disorder. Front. Psychiatry, 2021, 12, 585742. doi: 10.3389/fpsyt.2021.585742 PMID: 33679468
- Carlsson, E.; Frostell, A.; Ludvigsson, J.; Faresjö, M. Psychological stress in children may alter the immune response. J. Immunol., 2014, 192(5), 2071-2081. doi: 10.4049/jimmunol.1301713 PMID: 24501202
- Khandaker, G.M.; Pearson, R.M.; Zammit, S.; Lewis, G.; Jones, P.B. Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: A population-based longitudinal study. JAMA Psychiatry, 2014, 71(10), 1121-1128. doi: 10.1001/jamapsychiatry.2014.1332 PMID: 25133871
- Föcking, M.; Sabherwal, S.; Cates, H.M.; Scaife, C.; Dicker, P.; Hryniewiecka, M.; Wynne, K.; Rutten, B.P.F.; Lewis, G.; Cannon, M.; Nestler, E.J.; Heurich, M.; Cagney, G.; Zammit, S.; Cotter, D.R. Complement pathway changes at age 12 are associated with psychotic experiences at age 18 in a longitudinal population-based study: Evidence for a role of stress. Mol. Psychiatry, 2021, 26(2), 524-533. doi: 10.1038/s41380-018-0306-z PMID: 30635638
- Pillinger, T.; Osimo, E.F.; Brugger, S.; Mondelli, V.; McCutcheon, R.A.; Howes, O.D. A meta-analysis of immune parameters, variability, and assessment of modal distribution in psychosis and test of the immune subgroup hypothesis. Schizophr. Bull., 2019, 45(5), 1120-1133. doi: 10.1093/schbul/sby160 PMID: 30407606
- Miller, B.J.; Gassama, B.; Sebastian, D.; Buckley, P.; Mellor, A. Meta-analysis of lymphocytes in schizophrenia: Clinical status and antipsychotic effects. Biol. Psychiatry, 2013, 73(10), 993-999. doi: 10.1016/j.biopsych.2012.09.007 PMID: 23062357
- Miller, B.J.; Buckley, P.; Seabolt, W.; Mellor, A.; Kirkpatrick, B. Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects. Biol. Psychiatry, 2011, 70(7), 663-671. doi: 10.1016/j.biopsych.2011.04.013 PMID: 21641581
- Mondelli, V.; Ciufolini, S.; Belvederi Murri, M.; Bonaccorso, S.; Di Forti, M.; Giordano, A.; Marques, T.R.; Zunszain, P.A.; Morgan, C.; Murray, R.M.; Pariante, C.M.; Dazzan, P. Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis. Schizophr. Bull., 2015, 41(5), 1162-1170. doi: 10.1093/schbul/sbv028 PMID: 25829375
- Steiner, J.; Jacobs, R.; Panteli, B.; Brauner, M.; Schiltz, K.; Bahn, S.; Herberth, M.; Westphal, S.; Gos, T.; Walter, M.; Bernstein, H.G.; Myint, A.M.; Bogerts, B. Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity. Eur. Arch. Psychiatry Clin. Neurosci., 2010, 260(7), 509-518. doi: 10.1007/s00406-010-0098-x PMID: 20107825
- Di Nicola, M.; Cattaneo, A.; Hepgul, N.; Di Forti, M.; Aitchison, K.J.; Janiri, L.; Murray, R.M.; Dazzan, P.; Pariante, C.M.; Mondelli, V. Serum and gene expression profile of cytokines in first-episode psychosis. Brain Behav. Immun., 2013, 31, 90-95. doi: 10.1016/j.bbi.2012.06.010 PMID: 22749891
- Corsi-Zuelli, F.; Loureiro, C.M.; Shuhama, R.; Fachim, H.A.; Menezes, P.R.; Louzada-Junior, P.; Mondelli, V.; Del-Ben, C.M. Cytokine profile in first-episode psychosis, unaffected siblings and community-based controls: The effects of familial liability and childhood maltreatment. Psychol. Med., 2020, 50(7), 1139-1147. doi: 10.1017/S0033291719001016 PMID: 31064423
- Misiak, B.; Bartoli, F.; Carrà, G.; Stańczykiewicz, B.; Gładka, A.; Frydecka, D.; Samochowiec, J.; Jarosz, K.; Hadryś, T.; Miller, B.J. Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis. Psychoneuroendocrinology, 2021, 127, 105200. doi: 10.1016/j.psyneuen.2021.105200 PMID: 33740587
- Perkins, D.O.; Jeffries, C.D.; Addington, J.; Bearden, C.E.; Cadenhead, K.S.; Cannon, T.D.; Cornblatt, B.A.; Mathalon, D.H.; McGlashan, T.H.; Seidman, L.J.; Tsuang, M.T.; Walker, E.F.; Woods, S.W.; Heinssen, R. Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: Preliminary results from the NAPLS project. Schizophr. Bull., 2015, 41(2), 419-428. doi: 10.1093/schbul/sbu099 PMID: 25103207
- Mongan, D.; Focking, M.; Healy, C.; Susai, S.R.; Heurich, M.; Wynne, K.; Nelson, B.; McGorry, P.D.; Amminger, G.P.; Nordentoft, M.; Krebs, M.O.; Riecher-Rossler, A.; Bressan, R.A.; Barrantes-Vidal, N.; Borgwardt, S.; Ruhrmann, S.; Sachs, G.; Pantelis, C.; van der Gaag, M.; de Haan, L.; Valmaggia, L.; Pollak, T.A.; Kempton, M.J.; Rutten, B.P.F.; Whelan, R.; Cannon, M.; Zammit, S.; Cagney, G.; Cotter, D.R.; McGuire, P. European network of national schizophrenia networks studying gene-environment interactions high risk study, g. development of proteomic prediction models for transition to psychotic disorder in the clinical high-risk state and psychotic experiences in adolescence. JAMA Psychiatry, 2021, 78(1), 77-90. doi: 10.1001/jamapsychiatry.2020.2459 PMID: 32857162
- Pollak, T.A.; Kempton, M.J.; Iyegbe, C.; Vincent, A.; Irani, S.R.; Coutinho, E.; Menassa, D.A.; Jacobson, L.; de Haan, L.; Ruhrmann, S.; Sachs, G.; Riecher-Rössler, A.; Krebs, M.O.; Amminger, P.; Glenthøj, B.; Barrantes-Vidal, N.; van Os, J.; Rutten, B.P.F.; Bressan, R.A.; van der Gaag, M.; Yolken, R.; Hotopf, M.; Valmaggia, L.; Stone, J.; David, A.S.; Calem, M.; Tognin, S.; Modinos, G.; de Haan, L.; van der Gaag, M.; Velthorst, E.; Kraan, T.C.; van Dam, D.S.; Burger, N.; Nelson, B.; McGorry, P.; Pantelis, C.; Politis, A.; Goodall, J.; Borgwardt, S.; Ittig, S.; Studerus, E.; Smieskova, R.; Gadelha, A.; Brietzke, E.; Asevedo, G.; Asevedo, E.; Zugman, A.; Rosa, A.; Racioppi, A.; Monsonet, M.; Hinojosa-Marqués, L.; Kwapil, T.R.; Kazes, M.; Daban, C.; Bourgin, J.; Gay, O.; Mam-Lam-Fook, C.; Nordholm, D.; Randers, L.; Krakauer, K.; Glenthøj, L.; Nordentoft, M.; Gebhard, D.; Arnhold, J.; Klosterkötter, J.; Lasser, I.; Winklbaur, B.; Delespaul, P.A.; van Os, J.; McGuire, P. Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis. Mol. Psychiatry, 2021, 26(6), 2590-2604. doi: 10.1038/s41380-020-00899-w PMID: 33077853
- Smith, S.M.; Vale, W.W. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin. Neurosci., 2006, 8(4), 383-395. doi: 10.31887/DCNS.2006.8.4/ssmith PMID: 17290797
- McEwen, B.S.; Nasca, C.; Gray, J.D. Stress effects on neuronal structure: Hippocampus, amygdala, and prefrontal cortex. Neuropsychopharmacology, 2016, 41(1), 3-23. doi: 10.1038/npp.2015.171 PMID: 26076834
- Lupien, S.J.; Juster, R.P.; Raymond, C.; Marin, M.F. The effects of chronic stress on the human brain: From neurotoxicity, to vulnerability, to opportunity. Front. Neuroendocrinol., 2018, 49, 91-105. doi: 10.1016/j.yfrne.2018.02.001 PMID: 29421159
- Lupien, S.J.; McEwen, B.S.; Gunnar, M.R.; Heim, C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat. Rev. Neurosci., 2009, 10(6), 434-445. doi: 10.1038/nrn2639 PMID: 19401723
- Filiano, A.J.; Xu, Y.; Tustison, N.J.; Marsh, R.L.; Baker, W.; Smirnov, I.; Overall, C.C.; Gadani, S.P.; Turner, S.D.; Weng, Z.; Peerzade, S.N.; Chen, H.; Lee, K.S.; Scott, M.M.; Beenhakker, M.P.; Litvak, V.; Kipnis, J. Unexpected role of interferon-γ in regulating neuronal connectivity and social behaviour. Nature, 2016, 535(7612), 425-429. doi: 10.1038/nature18626 PMID: 27409813
- Howes, O.D.; McCutcheon, R. Inflammation and the neural diathesis-stress hypothesis of schizophrenia: A reconceptualization. Transl. Psychiatry, 2017, 7(2), e1024. doi: 10.1038/tp.2016.278 PMID: 28170004
- Reynolds, R.M.; Labad, J.; Buss, C.; Ghaemmaghami, P.; Räikkönen, K. Transmitting biological effects of stress in utero: Implications for mother and offspring. Psychoneuroendocrinology, 2013, 38(9), 1843-1849. doi: 10.1016/j.psyneuen.2013.05.018 PMID: 23810315
- Humphreys, K.L.; Camacho, M.C.; Roth, M.C.; Estes, E.C. Prenatal stress exposure and multimodal assessment of amygdalamedial prefrontal cortex connectivity in infants. Dev. Cogn. Neurosci., 2020, 46, 100877. doi: 10.1016/j.dcn.2020.100877 PMID: 33220629
- Sandman, C.A.; Curran, M.M.; Davis, E.P.; Glynn, L.M.; Head, K.; Baram, T.Z. Cortical thinning and neuropsychiatric outcomes in children exposed to prenatal adversity: A role for placental CRH? Am. J. Psychiatry, 2018, 175(5), 471-479. doi: 10.1176/appi.ajp.2017.16121433 PMID: 29495899
- Paquola, C.; Bennett, M.R.; Lagopoulos, J. Understanding heterogeneity in grey matter research of adults with childhood maltreatmentA meta-analysis and review. Neurosci. Biobehav. Rev., 2016, 69, 299-312. doi: 10.1016/j.neubiorev.2016.08.011 PMID: 27531235
- Heany, S.J.; Groenewold, N.A.; Uhlmann, A.; Dalvie, S.; Stein, D.J.; Brooks, S.J. The neural correlates of Childhood Trauma Questionnaire scores in adults: A meta-analysis and review of functional magnetic resonance imaging studies. Dev. Psychopathol., 2018, 30(4), 1475-1485. doi: 10.1017/S0954579417001717 PMID: 29224580
- Herringa, R.J.; Birn, R.M.; Ruttle, P.L.; Burghy, C.A.; Stodola, D.E.; Davidson, R.J.; Essex, M.J. Childhood maltreatment is associated with altered fear circuitry and increased internalizing symptoms by late adolescence. Proc. Natl. Acad. Sci., 2013, 110(47), 19119-19124. doi: 10.1073/pnas.1310766110 PMID: 24191026
- Rapado-Castro, M.; Whittle, S.; Pantelis, C.; Thompson, A.; Nelson, B.; Ganella, E.P.; Lin, A.; Reniers, R.L.E.P.; McGorry, P.D.; Yung, A.R.; Wood, S.J.; Bartholomeusz, C.F. Does cortical brain morphology act as a mediator between childhood trauma and transition to psychosis in young individuals at ultra-high risk? Schizophr. Res., 2020, 224, 116-125. doi: 10.1016/j.schres.2020.09.017 PMID: 33071072
- LoPilato, A.M.; Goines, K.; Addington, J.; Bearden, C.E.; Cadenhead, K.S.; Cannon, T.D.; Cornblatt, B.A.; Mathalon, D.H.; McGlashan, T.H.; Seidman, L.; Perkins, D.O.; Tsuang, M.T.; Woods, S.W.; Walker, E.F. Impact of childhood adversity on corticolimbic volumes in youth at clinical high-risk for psychosis. Schizophr. Res., 2019, 213, 48-55. doi: 10.1016/j.schres.2019.01.048 PMID: 30745068
- Allen, P.; Azis, M.; Modinos, G.; Bossong, M.G.; Bonoldi, I.; Samson, C.; Quinn, B.; Kempton, M.J.; Howes, O.D.; Stone, J.M.; Calem, M.; Perez, J.; Bhattacharayya, S.; Broome, M.R.; Grace, A.A.; Zelaya, F.; McGuire, P. Increased resting hippocampal and basal ganglia perfusion in people at ultra high risk for psychosis: Replication in a second cohort. Schizophr. Bull., 2018, 44(6), 1323-1331. doi: 10.1093/schbul/sbx169 PMID: 29294102
- Mondelli, V.; Pariante, C.M.; Navari, S.; Aas, M.; DAlbenzio, A.; Di Forti, M.; Handley, R.; Hepgul, N.; Marques, T.R.; Taylor, H.; Papadopoulos, A.S.; Aitchison, K.J.; Murray, R.M.; Dazzan, P. Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis. Schizophr. Res., 2010, 119(1-3), 75-78. doi: 10.1016/j.schres.2009.12.021 PMID: 20071148
- Mondelli, V.; Cattaneo, A.; Murri, M.B.; Di Forti, M.; Handley, R.; Hepgul, N.; Miorelli, A.; Navari, S.; Papadopoulos, A.S.; Aitchison, K.J.; Morgan, C.; Murray, R.M.; Dazzan, P.; Pariante, C.M. Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: A pathway to smaller hippocampal volume. J. Clin. Psychiatry, 2011, 72(12), 1677-1684. doi: 10.4088/JCP.10m06745 PMID: 21672499
- Pruessner, M.; Lepage, M.; Collins, D.L.; Pruessner, J.C.; Joober, R.; Malla, A.K. Reduced hippocampal volume and hypothalamuspituitaryadrenal axis function in first episode psychosis: Evidence for sex differences. Neuroimage Clin., 2015, 7, 195-202. doi: 10.1016/j.nicl.2014.12.001 PMID: 25610781
- Pruessner, M.; Bechard-Evans, L.; Pira, S.; Joober, R.; Collins, D.L.; Pruessner, J.C.; Malla, A.K. Interplay of hippocampal volume and hypothalamus-pituitary-adrenal axis function as markers of stress vulnerability in men at ultra-high risk for psychosis. Psychol. Med., 2017, 47(3), 471-483. doi: 10.1017/S0033291716002658 PMID: 27774914
- Kose, M.; Pariante, C.M.; Dazzan, P.; Mondelli, V. The role of peripheral inflammation in clinical outcome and brain imaging abnormalities in psychosis: A systematic review. Front. Psychiatry, 2021, 12, 612471. doi: 10.3389/fpsyt.2021.612471 PMID: 33679475
- Quidé, Y.; Girshkin, L.; Watkeys, O.J.; Carr, V.J.; Green, M.J. The relationship between cortisol reactivity and emotional brain function is differently moderated by childhood trauma, in bipolar disorder, schizophrenia and healthy individuals. Eur. Arch. Psychiatry Clin. Neurosci., 2021, 271(6), 1089-1109. doi: 10.1007/s00406-020-01190-3 PMID: 32926285
- Cannon, T.D.; Chung, Y.; He, G.; Sun, D.; Jacobson, A.; van Erp, T.G.M.; McEwen, S.; Addington, J.; Bearden, C.E.; Cadenhead, K.; Cornblatt, B.; Mathalon, D.H.; McGlashan, T.; Perkins, D.; Jeffries, C.; Seidman, L.J.; Tsuang, M.; Walker, E.; Woods, S.W.; Heinssen, R. Progressive reduction in cortical thickness as psychosis develops: A multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol. Psychiatry, 2015, 77(2), 147-157. doi: 10.1016/j.biopsych.2014.05.023 PMID: 25034946
- Mauri, M.; Sinforiani, E.; Bono, G.; Vignati, F.; Berselli, M.E.; Attanasio, R.; Nappi, G. Memory impairment in Cushings disease. Acta Neurol. Scand., 1993, 87(1), 52-55. doi: 10.1111/j.1600-0404.1993.tb04075.x PMID: 8424312
- Resmini, E.; Santos, A.; Gómez-Anson, B.; Vives, Y.; Pires, P.; Crespo, I.; Portella, M.J.; de Juan-Delago, M.; Barahona, M.J.; Webb, S.M. Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushings syndrome. J. Clin. Endocrinol. Metab., 2012, 97(2), 663-671. doi: 10.1210/jc.2011-2231 PMID: 22162471
- Bourdeau, I.; Bard, C.; Noël, B.; Leclerc, I.; Cordeau, M.P.; Bélair, M.; Lesage, J.; Lafontaine, L.; Lacroix, A. Loss of brain volume in endogenous Cushings syndrome and its reversibility after correction of hypercortisolism. J. Clin. Endocrinol. Metab., 2002, 87(5), 1949-1954. PMID: 11994323
- Starkman, M.N. Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration. Endocrinol. Metab. Clin. North Am., 2013, 42(3), 477-488. doi: 10.1016/j.ecl.2013.05.010 PMID: 24011881
- Resmini, E.; Santos, A.; Webb, S.M. Cortisol excess and the brain. Front. Horm. Res., 2016, 46, 74-86. doi: 10.1159/000443868 PMID: 27210466
- Lupien, S.J.; Schwartz, G.; Ng, Y.K.; Fiocco, A.; Wan, N.; Pruessner, J.C.; Meaney, M.J.; Nair, N.P. The douglas hospital longitudinal study of normal and pathological aging: Summary of findings. J. Psychiatry Neurosci., 2005, 30(5), 328-334. PMID: 16151537
- Zheng, B.; Tal, R.; Yang, Z.; Middleton, L.; Udeh-Momoh, C. Cortisol hypersecretion and the risk of Alzheimers disease: A systematic review and meta-analysis. Ageing Res. Rev., 2020, 64, 101171. doi: 10.1016/j.arr.2020.101171 PMID: 32971258
- Green, M.F.; Horan, W.P.; Lee, J. Nonsocial and social cognition in schizophrenia: Current evidence and future directions. World Psychiatry, 2019, 18(2), 146-161. doi: 10.1002/wps.20624 PMID: 31059632
- Fusar-Poli, P.; Deste, G.; Smieskova, R.; Barlati, S.; Yung, A.R.; Howes, O.; Stieglitz, R.D.; Vita, A.; McGuire, P.; Borgwardt, S. Cognitive functioning in prodromal psychosis: a meta-analysis. Arch. Gen. Psychiatry, 2012, 69(6), 562-571. doi: 10.1001/archgenpsychiatry.2011.1592 PMID: 22664547
- Millman, Z.B.; Roemer, C.; Vargas, T.; Schiffman, J.; Mittal, V.A.; Gold, J.M. Neuropsychological performance among individuals at clinical high-risk for psychosis vs putatively low-risk peers with other psychopathology: A systematic review and meta-analysis. Schizophr. Bull., 2022, 48(5), 999-1010. doi: 10.1093/schbul/sbac031 PMID: 35333372
- Havelka, D.; Prikrylova-Kucerova, H.; Prikryl, R.; Ceskova, E. Cognitive impairment and cortisol levels in first-episode schizophrenia patients. Stress, 2016, 19(4), 383-389. doi: 10.1080/10253890.2016.1193146 PMID: 27320489
- Aas, M.; Pizzagalli, D.A.; Laskemoen, J.F.; Reponen, E.J.; Ueland, T.; Melle, I.; Agartz, I.; Steen, N.E.; Andreassen, O.A. Elevated hair cortisol is associated with childhood maltreatment and cognitive impairment in schizophrenia and in bipolar disorders. Schizophr. Res., 2019, 213, 65-71. doi: 10.1016/j.schres.2019.01.011 PMID: 30660575
- Aas, M.; Dazzan, P.; Fisher, H.L.; Morgan, C.; Morgan, K.; Reichenberg, A.; Zanelli, J.; Fearon, P.; Jones, P.B.; Murray, R.M.; Pariante, C.M. Childhood trauma and cognitive function in first-episode affective and non-affective psychosis. Schizophr. Res., 2011, 129(1), 12-19. doi: 10.1016/j.schres.2011.03.017 PMID: 21601792
- Cullen, A.E.; Zunszain, P.A.; Dickson, H.; Roberts, R.E.; Fisher, H.L.; Pariante, C.M.; Laurens, K.R. Cortisol awakening response and diurnal cortisol among children at elevated risk for schizophrenia: Relationship to psychosocial stress and cognition. Psychoneuroendocrinology, 2014, 46(100), 1-13. doi: 10.1016/j.psyneuen.2014.03.010 PMID: 24882153
- Labad, J.; Gutiérrez-Zotes, A.; Creus, M.; Montalvo, I.; Cabezas, Á.; Solé, M.; Ortega, L.; Algora, M.J.; Sánchez-Gistau, V.; Vilella, E. Hypothalamic-pituitary-adrenal axis measures and cognitive abilities in early psychosis: Are there sex differences? Psychoneuroendocrinology, 2016, 72, 54-62. doi: 10.1016/j.psyneuen.2016.06.006 PMID: 27344379
- Khandaker, G.M.; Cousins, L.; Deakin, J.; Lennox, B.R.; Yolken, R.; Jones, P.B. Inflammation and immunity in schizophrenia: Implications for pathophysiology and treatment. Lancet Psychiatry, 2015, 2(3), 258-270. doi: 10.1016/S2215-0366(14)00122-9 PMID: 26359903
- Morrens, M.; Overloop, C.; Coppens, V.; Loots, E.; Van Den Noortgate, M.; Vandenameele, S.; Leboyer, M.; De Picker, L. The relationship between immune and cognitive dysfunction in mood and psychotic disorder: A systematic review and a meta-analysis. Mol. Psychiatry, 2022, 27(8), 3237-3246. doi: 10.1038/s41380-022-01582-y PMID: 35484245
- Patlola, S.R.; Donohoe, G.; McKernan, D.P. The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: A systematic review and meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2023, 121, 110668. doi: 10.1016/j.pnpbp.2022.110668 PMID: 36283512
- Thursby, E.; Juge, N. Introduction to the human gut microbiota. Biochem. J., 2017, 474(11), 1823-1836. doi: 10.1042/BCJ20160510 PMID: 28512250
- Qin, J.; Li, R.; Raes, J.; Arumugam, M.; Burgdorf, K.S.; Manichanh, C.; Nielsen, T.; Pons, N.; Levenez, F.; Yamada, T.; Mende, D.R.; Li, J.; Xu, J.; Li, S.; Li, D.; Cao, J.; Wang, B.; Liang, H.; Zheng, H.; Xie, Y.; Tap, J.; Lepage, P.; Bertalan, M.; Batto, J.M.; Hansen, T.; Le Paslier, D.; Linneberg, A.; Nielsen, H.B.; Pelletier, E.; Renault, P.; Sicheritz-Ponten, T.; Turner, K.; Zhu, H.; Yu, C.; Li, S.; Jian, M.; Zhou, Y.; Li, Y.; Zhang, X.; Li, S.; Qin, N.; Yang, H.; Wang, J.; Brunak, S.; Doré, J.; Guarner, F.; Kristiansen, K.; Pedersen, O.; Parkhill, J.; Weissenbach, J.; Bork, P.; Ehrlich, S.D.; Wang, J.; Wang, J. A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 2010, 464(7285), 59-65. doi: 10.1038/nature08821 PMID: 20203603
- Sender, R.; Fuchs, S.; Milo, R. Are we really vastly outnumbered? revisiting the ratio of bacterial to host cells in humans. Cell, 2016, 164(3), 337-340. doi: 10.1016/j.cell.2016.01.013 PMID: 26824647
- Dinan, T.G.; Cryan, J.F. Brain-gut-microbiota axis and mental health. Psychosom. Med., 2017, 79(8), 920-926. doi: 10.1097/PSY.0000000000000519 PMID: 28806201
- de Weerth, C. Do bacteria shape our development? crosstalk between intestinal microbiota and HPA axis. Neurosci. Biobehav. Rev., 2017, 83, 458-471. doi: 10.1016/j.neubiorev.2017.09.016 PMID: 28918360
- Hantsoo, L.; Zemel, B.S. Stress gets into the belly: Early life stress and the gut microbiome. Behav. Brain Res., 2021, 414, 113474. doi: 10.1016/j.bbr.2021.113474 PMID: 34280457
- Kelly, J.R.; Minuto, C.; Cryan, J.F.; Clarke, G.; Dinan, T.G. The role of the gut microbiome in the development of schizophrenia. Schizophr. Res., 2021, 234, 4-23. doi: 10.1016/j.schres.2020.02.010 PMID: 32336581
- Zijlmans, M.A.C.; Korpela, K.; Riksen-Walraven, J.M.; de Vos, W.M.; de Weerth, C. Maternal prenatal stress is associated with the infant intestinal microbiota. Psychoneuroendocrinology, 2015, 53, 233-245. doi: 10.1016/j.psyneuen.2015.01.006 PMID: 25638481
- Jaarević, E.; Howerton, C.L.; Howard, C.D.; Bale, T.L. Alterations in the vaginal microbiome by maternal stress are associated with metabolic reprogramming of the offspring gut and brain. Endocrinology, 2015, 156(9), 3265-3276. doi: 10.1210/en.2015-1177 PMID: 26079804
- Flannery, J.E.; Stagaman, K.; Burns, A.R.; Hickey, R.J.; Roos, L.E.; Giuliano, R.J.; Fisher, P.A.; Sharpton, T.J. Gut feelings begin in childhood: The gut metagenome correlates with early environment, caregiving, and behavior. MBio, 2020, 11(1), e02780-e19. doi: 10.1128/mBio.02780-19 PMID: 31964729
- Reid, B.M.; Horne, R.; Donzella, B.; Szamosi, J.C.; Coe, C.L.; Foster, J.A.; Gunnar, M.R. Microbiota‐immune alterations in adolescents following early life adversity: A proof of concept study. Dev. Psychobiol., 2021, 63(5), 851-863. doi: 10.1002/dev.22061 PMID: 33249563
- Bailey, M.T.; Coe, C.L. Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys. Dev. Psychobiol., 1999, 35(2), 146-155. doi: 10.1002/(SICI)1098-2302(199909)35:23.0.CO;2-G PMID: 10461128
- OMahony, S.M.; Marchesi, J.R.; Scully, P.; Codling, C.; Ceolho, A.M.; Quigley, E.M.M.; Cryan, J.F.; Dinan, T.G. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol. Psychiatry, 2009, 65(3), 263-267. doi: 10.1016/j.biopsych.2008.06.026 PMID: 18723164
- Vangay, P.; Johnson, A.J.; Ward, T.L.; Al-Ghalith, G.A.; Shields-Cutler, R.R.; Hillmann, B.M.; Lucas, S.K.; Beura, L.K.; Thompson, E.A.; Till, L.M.; Batres, R.; Paw, B.; Pergament, S.L.; Saenyakul, P.; Xiong, M.; Kim, A.D.; Kim, G.; Masopust, D.; Martens, E.C.; Angkurawaranon, C.; McGready, R.; Kashyap, P.C.; Culhane-Pera, K.A.; Knights, D. US immigration westernizes the human gut microbiome. Cell, 2018, 175(4), 962-972.e10. doi: 10.1016/j.cell.2018.10.029 PMID: 30388453
- Mancabelli, L.; Milani, C.; Lugli, G.A.; Turroni, F.; Ferrario, C.; van Sinderen, D.; Ventura, M. Meta-analysis of the human gut microbiome from urbanized and pre-agricultural populations. Environ. Microbiol., 2017, 19(4), 1379-1390. doi: 10.1111/1462-2920.13692 PMID: 28198087
- Luczynski, P.; McVey Neufeld, K.A.; Oriach, C.S.; Clarke, G.; Dinan, T.G.; Cryan, J.F. Growing up in a bubble: Using germ-free animals to assess the influence of the gut microbiota on brain and behavior. Int. J. Neuropsychopharmacol., 2016, 19(8), pyw020. doi: 10.1093/ijnp/pyw020 PMID: 26912607
- Degroote, S.; Hunting, D.J.; Baccarelli, A.A.; Takser, L. Maternal gut and fetal brain connection: Increased anxiety and reduced social interactions in wistar rat offspring following peri-conceptional antibiotic exposure. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2016, 71, 76-82. doi: 10.1016/j.pnpbp.2016.06.010 PMID: 27346743
- Leclercq, S.; Mian, F.M.; Stanisz, A.M.; Bindels, L.B.; Cambier, E.; Ben-Amram, H.; Koren, O.; Forsythe, P.; Bienenstock, J. Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior. Nat. Commun., 2017, 8(1), 15062. doi: 10.1038/ncomms15062 PMID: 28375200
- Lieberman, J.A.; Girgis, R.R.; Brucato, G.; Moore, H.; Provenzano, F.; Kegeles, L.; Javitt, D.; Kantrowitz, J.; Wall, M.M.; Corcoran, C.M.; Schobel, S.A.; Small, S.A. Hippocampal dysfunction in the pathophysiology of schizophrenia: A selective review and hypothesis for early detection and intervention. Mol. Psychiatry, 2018, 23(8), 1764-1772. doi: 10.1038/mp.2017.249 PMID: 29311665
- Rea, K.; Dinan, T.G.; Cryan, J.F. The microbiome: A key regulator of stress and neuroinflammation. Neurobiol. Stress, 2016, 4, 23-33. doi: 10.1016/j.ynstr.2016.03.001 PMID: 27981187
- Schmidt, K.; Cowen, P.J.; Harmer, C.J.; Tzortzis, G.; Errington, S.; Burnet, P.W.J. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology, 2015, 232(10), 1793-1801. doi: 10.1007/s00213-014-3810-0 PMID: 25449699
- Messaoudi, M.; Violle, N.; Bisson, J.F.; Desor, D.; Javelot, H.; Rougeot, C. Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in healthy human volunteers. Gut Microbes, 2011, 2(4), 256-261. doi: 10.4161/gmic.2.4.16108 PMID: 21983070
- de Weerth, C.; Zijl, R.H.; Buitelaar, J.K. Development of cortisol circadian rhythm in infancy. Early Hum. Dev., 2003, 73(1-2), 39-52. doi: 10.1016/S0378-3782(03)00074-4 PMID: 12932892
- de Weerth, C.; Fuentes, S.; Puylaert, P.; de Vos, W.M. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics, 2013, 131(2), e550-e558. doi: 10.1542/peds.2012-1449 PMID: 23319531
- Chu, D.M.; Ma, J.; Prince, A.L.; Antony, K.M.; Seferovic, M.D.; Aagaard, K.M. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat. Med., 2017, 23(3), 314-326. doi: 10.1038/nm.4272 PMID: 28112736
- Underwood, M.A.; German, J.B.; Lebrilla, C.B.; Mills, D.A. Bifidobacterium longum subspecies infantis: Champion colonizer of the infant gut. Pediatr. Res., 2015, 77(1-2), 229-235. doi: 10.1038/pr.2014.156 PMID: 25303277
- Dinan, T.G.; Stilling, R.M.; Stanton, C.; Cryan, J.F. Collective unconscious: How gut microbes shape human behavior. J. Psychiatr. Res., 2015, 63, 1-9. doi: 10.1016/j.jpsychires.2015.02.021 PMID: 25772005
- Dinan, T.G.; Kennedy, P.J.; Morais, L.H.; Murphy, A.; Long-Smith, C.M.; Moloney, G.M.; Bastiaanssen, T.F.S.; Allen, A.P.; Collery, A.; Mullins, D.; Cusack, A.M.; Berding, K.; OToole, P.W.; Clarke, G.; Stanton, C.; Cryan, J.F. Altered stress responses in adults born by Caesarean section. Neurobiol. Stress, 2022, 16, 100425. doi: 10.1016/j.ynstr.2021.100425 PMID: 35024387
- Dalla Costa, G.; Romeo, M.; Esposito, F.; Sangalli, F.; Colombo, B.; Radaelli, M.; Moiola, L.; Comi, G.; Martinelli, V. Caesarean section and infant formula feeding are associated with an earlier age of onset of multiple sclerosis. Mult. Scler. Relat. Disord., 2019, 33, 75-77. doi: 10.1016/j.msard.2019.05.010 PMID: 31158806
- ONeill, S.M.; Curran, E.A.; Dalman, C.; Kenny, L.C.; Kearney, P.M.; Clarke, G.; Cryan, J.F.; Dinan, T.G.; Khashan, A.S. Birth by caesarean section and the risk of adult psychosis: A population-based cohort study. Schizophr. Bull., 2016, 42(3), 633-641. doi: 10.1093/schbul/sbv152 PMID: 26615187
- Safadi, J.M.; Quinton, A.M.G.; Lennox, B.R.; Burnet, P.W.J.; Minichino, A. Gut dysbiosis in severe mental illness and chronic fatigue: a novel trans-diagnostic construct? A systematic review and meta-analysis. Mol. Psychiatry, 2022, 27(1), 141-153. doi: 10.1038/s41380-021-01032-1 PMID: 33558650
- Nikolova, V.L.; Smith, M.R.B.; Hall, L.J.; Cleare, A.J.; Stone, J.M.; Young, A.H. Perturbations in gut microbiota composition in psychiatric disorders. JAMA Psychiatry, 2021, 78(12), 1343-1354. doi: 10.1001/jamapsychiatry.2021.2573 PMID: 34524405
- Zhu, F.; Guo, R.; Wang, W.; Ju, Y.; Wang, Q.; Ma, Q.; Sun, Q.; Fan, Y.; Xie, Y.; Yang, Z.; Jie, Z.; Zhao, B.; Xiao, L.; Yang, L.; Zhang, T.; Liu, B.; Guo, L.; He, X.; Chen, Y.; Chen, C.; Gao, C.; Xu, X.; Yang, H.; Wang, J.; Dang, Y.; Madsen, L.; Brix, S.; Kristiansen, K.; Jia, H.; Ma, X. Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice. Mol. Psychiatry, 2020, 25(11), 2905-2918. doi: 10.1038/s41380-019-0475-4 PMID: 31391545
- Zheng, P.; Zeng, B.; Liu, M.; Chen, J.; Pan, J.; Han, Y.; Liu, Y.; Cheng, K.; Zhou, C.; Wang, H.; Zhou, X.; Gui, S.; Perry, S.W.; Wong, M.L.; Licinio, J.; Wei, H.; Xie, P. The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci. Adv., 2019, 5(2), eaau8317. doi: 10.1126/sciadv.aau8317 PMID: 30775438
- Schwarz, E.; Maukonen, J.; Hyytiäinen, T.; Kieseppä, T.; Oreič, M.; Sabunciyan, S.; Mantere, O.; Saarela, M.; Yolken, R.; Suvisaari, J. Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response. Schizophr. Res., 2018, 192, 398-403. doi: 10.1016/j.schres.2017.04.017 PMID: 28442250
- He, Y.; Kosciolek, T.; Tang, J.; Zhou, Y.; Li, Z.; Ma, X.; Zhu, Q.; Yuan, N.; Yuan, L.; Li, C.; Jin, K.; Knight, R.; Tsuang, M.T.; Chen, X. Gut microbiome and magnetic resonance spectroscopy study of subjects at ultra-high risk for psychosis may support the membrane hypothesis. Eur. Psychiatry, 2018, 53, 37-45. doi: 10.1016/j.eurpsy.2018.05.011 PMID: 29870894
- Yuan, X.; Zhang, P.; Wang, Y.; Liu, Y.; Li, X.; Kumar, B.U.; Hei, G.; Lv, L.; Huang, X.F.; Fan, X.; Song, X. Changes in metabolism and microbiota after 24-week risperidone treatment in drug naïve, normal weight patients with first episode schizophrenia. Schizophr. Res., 2018, 201, 299-306. doi: 10.1016/j.schres.2018.05.017 PMID: 29859859
- Zheng, D.; Liwinski, T.; Elinav, E. Interaction between microbiota and immunity in health and disease. Cell Res., 2020, 30(6), 492-506. doi: 10.1038/s41422-020-0332-7 PMID: 32433595
- Petta, I.; Fraussen, J.; Somers, V.; Kleinewietfeld, M. Interrelation of diet, gut microbiome, and autoantibody production. Front. Immunol., 2018, 9, 439. doi: 10.3389/fimmu.2018.00439 PMID: 29559977
- Kim, M.; Kim, C.H. Regulation of humoral immunity by gut microbial products. Gut Microbes, 2017, 8(4), 392-399. doi: 10.1080/19490976.2017.1299311 PMID: 28332901
- Kennedy, P.J.; Cryan, J.F.; Dinan, T.G.; Clarke, G. Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology, 2017, 112((Pt B)), 399-412. doi: 10.1016/j.neuropharm.2016.07.002
- Dalile, B.; Van Oudenhove, L.; Vervliet, B.; Verbeke, K. The role of short-chain fatty acids in microbiotagutbrain communication. Nat. Rev. Gastroenterol. Hepatol., 2019, 16(8), 461-478. doi: 10.1038/s41575-019-0157-3 PMID: 31123355
- Minichino, A.; Jackson, M.A.; Francesconi, M.; Steves, C.J.; Menni, C.; Burnet, P.W.J.; Lennox, B.R. Endocannabinoid system mediates the association between gut-microbial diversity and anhedonia/amotivation in a general population cohort. Mol. Psychiatry, 2021, 26(11), 6269-6276. doi: 10.1038/s41380-021-01147-5 PMID: 34002020
- Sudo, N. Microbiome, HPA axis and production of endocrine hormones in the gut. Adv. Exp. Med. Biol., 2014, 817, 177-194. doi: 10.1007/978-1-4939-0897-4_8 PMID: 24997034
- Mondelli, V.; Dazzan, P.; Hepgul, N.; Di Forti, M.; Aas, M.; DAlbenzio, A.; Di Nicola, M.; Fisher, H.; Handley, R.; Marques, T.R.; Morgan, C.; Navari, S.; Taylor, H.; Papadopoulos, A.; Aitchison, K.J.; Murray, R.M.; Pariante, C.M. Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment. Schizophr. Res., 2010, 116(2-3), 234-242. doi: 10.1016/j.schres.2009.08.013 PMID: 19751968
- Cohrs, S.; Röher, C.; Jordan, W.; Meier, A.; Huether, G.; Wuttke, W.; Rüther, E.; Rodenbeck, A. The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects. Psychopharmacology, 2006, 185(1), 11-18. doi: 10.1007/s00213-005-0279-x PMID: 16432682
- Zhang, X.Y.; Zhou, D.F.; Cao, L.Y.; Wu, G.Y.; Shen, Y.C. Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics. Neuropsychopharmacology, 2005, 30(8), 1532-1538. doi: 10.1038/sj.npp.1300756 PMID: 15886721
- Capuzzi, E.; Bartoli, F.; Crocamo, C.; Clerici, M.; Carrà, G. Acute variations of cytokine levels after antipsychotic treatment in drug-naïve subjects with a first-episode psychosis: A meta-analysis. Neurosci. Biobehav. Rev., 2017, 77, 122-128. doi: 10.1016/j.neubiorev.2017.03.003 PMID: 28285148
- Seeman, M.V. The gut microbiome and antipsychotic treatment response. Behav. Brain Res., 2021, 396, 112886. doi: 10.1016/j.bbr.2020.112886 PMID: 32890599
- Maier, L.; Pruteanu, M.; Kuhn, M.; Zeller, G.; Telzerow, A.; Anderson, E.E.; Brochado, A.R.; Fernandez, K.C.; Dose, H.; Mori, H.; Patil, K.R.; Bork, P.; Typas, A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature, 2018, 555(7698), 623-628. doi: 10.1038/nature25979 PMID: 29555994
- Price, L.H.; Malison, R.T.; McDougle, C.J.; Pelton, G.H. Antiglucocorticoids as treatments for depression. CNS Drugs, 1996, 5(5), 311-320. doi: 10.2165/00023210-199605050-00001 PMID: 26071044
- Garner, B.; Phillips, L.J.; Bendall, S.; Hetrick, S.E. Antiglucocorticoid and related treatments for psychosis. Cochrane Database Syst. Rev., 2016, 1(1), CD006995. PMID: 26725721
- DeBattista, C.; Belanoff, J.; Glass, S.; Khan, A.; Horne, R.L.; Blasey, C.; Carpenter, L.L.; Alva, G. Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression. Biol. Psychiatry, 2006, 60(12), 1343-1349. doi: 10.1016/j.biopsych.2006.05.034 PMID: 16889757
- Lombardo, G.; Enache, D.; Gianotti, L.; Schatzberg, A.F.; Young, A.H.; Pariante, C.M.; Mondelli, V. Baseline cortisol and the efficacy of antiglucocorticoid treatment in mood disorders: A meta-analysis. Psychoneuroendocrinology, 2019, 110, 104420. doi: 10.1016/j.psyneuen.2019.104420 PMID: 31499391
- Nitta, M.; Kishimoto, T.; Müller, N.; Weiser, M.; Davidson, M.; Kane, J.M.; Correll, C.U. Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials. Schizophr. Bull., 2013, 39(6), 1230-1241. doi: 10.1093/schbul/sbt070 PMID: 23720576
- Jeppesen, R.; Christensen, R.H.B.; Pedersen, E.M.J.; Nordentoft, M.; Hjorthøj, C.; Köhler-Forsberg, O.; Benros, M.E. Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders A comprehensive systematic review and meta-analysis. Brain Behav. Immun., 2020, 90, 364-380. doi: 10.1016/j.bbi.2020.08.028 PMID: 32890697
- Girgis, R.R.; Ciarleglio, A.; Choo, T.; Haynes, G.; Bathon, J.M.; Cremers, S.; Kantrowitz, J.T.; Lieberman, J.A.; Brown, A.S. A randomized, double-blind, placebo-controlled clinical trial of tocilizumab, an interleukin-6 receptor antibody, for residual symptoms in schizophrenia. Neuropsychopharmacology, 2018, 43(6), 1317-1323. doi: 10.1038/npp.2017.258 PMID: 29090685
- Miller, B.J.; Goldsmith, D.R. Towards an immunophenotype of schizophrenia: Progress, potential mechanisms, and future directions. Neuropsychopharmacology, 2017, 42(1), 299-317. doi: 10.1038/npp.2016.211 PMID: 27654215
- Lee, Y.; Subramaniapillai, M.; Brietzke, E.; Mansur, R.B.; Ho, R.C.; Yim, S.J.; McIntyre, R.S. Anti-cytokine agents for anhedonia: Targeting inflammation and the immune system to treat dimensional disturbances in depression. Ther. Adv. Psychopharmacol., 2018, 8(12), 337-348. doi: 10.1177/2045125318791944 PMID: 30524702
- Berding, K.; Cryan, J.F. Microbiota-targeted interventions for mental health. Curr. Opin. Psychiatry, 2022, 35(1), 3-9. doi: 10.1097/YCO.0000000000000758 PMID: 34750307
- Mörkl, S.; Butler, M.I.; Holl, A.; Cryan, J.F.; Dinan, T.G. Probiotics and the microbiota-gut-brain axis: Focus on psychiatry. Curr. Nutr. Rep., 2020, 9(3), 171-182. doi: 10.1007/s13668-020-00313-5 PMID: 32406013
- Minichino, A.; Brondino, N.; Solmi, M.; Del Giovane, C.; Fusar-Poli, P.; Burnet, P.; Cipriani, A.; Lennox, B.R. The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies. Schizophr. Res., 2021, 234, 58-70. doi: 10.1016/j.schres.2020.02.012 PMID: 32295752
- Sepede, G.; Spano, M.C.; Lorusso, M.; De Berardis, D.; Salerno, R.M.; Di Giannantonio, M.; Gambi, F. Sustained attention in psychosis: Neuroimaging findings. World J. Radiol., 2014, 6(6), 261-273. doi: 10.4329/wjr.v6.i6.261 PMID: 24976929
- Mazza, M.; Caroppo, E.; De Berardis, D.; Marano, G.; Avallone, C.; Kotzalidis, G.D.; Janiri, D.; Moccia, L.; Simonetti, A.; Conte, E.; Martinotti, G.; Janiri, L.; Sani, G. Psychosis in women: Time for personalized treatment. J. Pers. Med., 2021, 11(12), 1279. doi: 10.3390/jpm11121279 PMID: 34945748
- Oliver, D.; Spada, G.; Englund, A.; Chesney, E.; Radua, J.; Reichenberg, A.; Uher, R.; McGuire, P.; Fusar-Poli, P. Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study. Schizophr. Res., 2020, 226, 176-183. doi: 10.1016/j.schres.2020.04.015 PMID: 32340785
- Oliver, D.; Radua, J.; Reichenberg, A.; Uher, R.; Fusar-Poli, P. Psychosis Polyrisk Score (PPS) for the detection of individuals at-risk and the prediction of their outcomes. Front. Psychiatry, 2019, 10, 174. doi: 10.3389/fpsyt.2019.00174 PMID: 31057431
- Baldwin, H.; Loebel-Davidsohn, L.; Oliver, D.; Salazar de Pablo, G.; Stahl, D.; Riper, H.; Fusar-Poli, P. Real-world implementation of precision psychiatry: A systematic review of barriers and facilitators. Brain Sci., 2022, 12(7), 934. doi: 10.3390/brainsci12070934 PMID: 35884740
- Salazar de Pablo, G.; Studerus, E.; Vaquerizo-Serrano, J.; Irving, J.; Catalan, A.; Oliver, D.; Baldwin, H.; Danese, A.; Fazel, S.; Steyerberg, E.W.; Stahl, D.; Fusar-Poli, P. Implementing precision psychiatry: A systematic review of individualized prediction models for clinical practice. Schizophr. Bull., 2021, 47(2), 284-297. doi: 10.1093/schbul/sbaa120 PMID: 32914178
- Meehan, A.J.; Lewis, S.J.; Fazel, S.; Fusar-Poli, P.; Steyerberg, E.W.; Stahl, D.; Danese, A. Clinical prediction models in psychiatry: A systematic review of two decades of progress and challenges. Mol. Psychiatry, 2022, 27(6), 2700-2708. doi: 10.1038/s41380-022-01528-4 PMID: 35365801
- Pries, L.K.; Lage-Castellanos, A.; Delespaul, P.; Kenis, G.; Luykx, J.J.; Lin, B.D.; Richards, A.L.; Akdede, B.; Binbay, T.; Altinyazar, V.; Yalinçetin, B.; Gümüş-Akay, G.; Cihan, B.; Soygür, H.; Ulaş, H.; Cankurtaran, E.Ş.; Kaymak, S.U.; Mihaljevic, M.M.; Petrovic, S.A.; Mirjanic, T.; Bernardo, M.; Cabrera, B.; Bobes, J.; Saiz, P.A.; García-Portilla, M.P.; Sanjuan, J.; Aguilar, E.J.; Santos, J.L.; Jiménez-López, E.; Arrojo, M.; Carracedo, A.; López, G.; González-Peñas, J.; Parellada, M.; Maric, N.P.; Atbaşoğlu, C.; Ucok, A.; Alptekin, K.; Saka, M.C.; Alizadeh, B.Z.; van Amelsvoort, T.; Bruggeman, R.; Cahn, W.; de Haan, L.; Luykx, J.J.; van Winkel, R.; Rutten, B.P.F.; van Os, J.; Arango, C.; ODonovan, M.; Rutten, B.P.F.; van Os, J.; Guloksuz, S. Estimating exposome score for schizophrenia using predictive modeling approach in two independent samples: The results from the EUGEI study. Schizophr. Bull., 2019, 45(5), 960-965. doi: 10.1093/schbul/sbz054 PMID: 31508804
- Jeon, E.J.; Kang, S.H.; Piao, Y.H.; Kim, S.W.; Kim, J.J.; Lee, B.J.; Yu, J.C.; Lee, K.Y.; Won, S.H.; Lee, S.H.; Kim, S.H.; Kim, E.T.; Kim, C.T.; Oliver, D.; Fusar-Poli, P.; Rami, F.Z.; Chung, Y.C. Development of the korea-polyenvironmental risk score for psychosis. Psychiatry Investig., 2022, 19(3), 197-206. doi: 10.30773/pi.2021.0328 PMID: 35196829
- Oliver, D. The importance of external validation to advance precision psychiatry. Lancet Reg. Health Eur., 2022, 22, 100498. doi: 10.1016/j.lanepe.2022.100498 PMID: 36061494
Arquivos suplementares
